2018-06-21 12:21:37,283:INFO: Disease Protein Prediction in the PPI Network
2018-06-21 12:21:37,283:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-21 12:21:37,283:INFO: ======================================
2018-06-21 12:21:37,283:INFO: Loading PPI Network...
2018-06-21 12:21:50,531:INFO: Loading Disease Associations...
2018-06-21 12:21:50,563:INFO: Loading PPI Matrix...
2018-06-21 12:23:43,785:INFO: Disease Protein Prediction in the PPI Network
2018-06-21 12:23:43,785:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-21 12:23:43,788:INFO: ======================================
2018-06-21 12:23:43,789:INFO: Loading PPI Network...
2018-06-21 12:23:56,105:INFO: Loading Disease Associations...
2018-06-21 12:23:56,134:INFO: Loading PPI Matrix...
2018-06-21 12:23:58,356:INFO: Running Experiment...
2018-06-21 12:23:58,357:INFO: Experiment Progress: 0.0% -- 0/519
2018-06-21 12:23:58,796:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 15.00%
2018-06-21 12:23:58,796:INFO: Experiment Progress: 0.0% -- 1/519
2018-06-21 12:23:59,224:INFO: Psychoses, Substance-Induced Recall-at-100: 25.00%
2018-06-21 12:23:59,224:INFO: Experiment Progress: 0.0% -- 2/519
2018-06-21 12:23:59,610:INFO: Zellweger Syndrome Recall-at-100: 90.00%
2018-06-21 12:23:59,611:INFO: Experiment Progress: 0.0% -- 3/519
2018-06-21 12:24:01,095:INFO: Psoriasis Recall-at-100: 6.67%
2018-06-21 12:24:01,095:INFO: Experiment Progress: 0.0% -- 4/519
2018-06-21 12:24:01,608:INFO: Nephrotic Syndrome Recall-at-100: 0.00%
2018-06-21 12:24:01,609:INFO: Experiment Progress: 0.0% -- 5/519
2018-06-21 12:24:02,267:INFO: Nephrosis Recall-at-100: 35.00%
2018-06-21 12:24:02,267:INFO: Experiment Progress: 1.0% -- 6/519
2018-06-21 12:24:02,638:INFO: Mouth Diseases Recall-at-100: 10.00%
2018-06-21 12:24:02,638:INFO: Experiment Progress: 1.0% -- 7/519
2018-06-21 12:24:03,030:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 76.67%
2018-06-21 12:24:03,030:INFO: Experiment Progress: 1.0% -- 8/519
2018-06-21 12:24:04,099:INFO: Substance-Related Disorders Recall-at-100: 1.00%
2018-06-21 12:24:04,100:INFO: Experiment Progress: 1.0% -- 9/519
2018-06-21 12:24:04,428:INFO: Anemia, Hemolytic Recall-at-100: 15.00%
2018-06-21 12:24:04,429:INFO: Experiment Progress: 1.0% -- 10/519
2018-06-21 12:24:06,270:INFO: Rheumatoid Arthritis Recall-at-100: 1.45%
2018-06-21 12:24:06,270:INFO: Experiment Progress: 2.0% -- 11/519
2018-06-21 12:24:06,638:INFO: Arthritis, Psoriatic Recall-at-100: 0.00%
2018-06-21 12:24:06,639:INFO: Experiment Progress: 2.0% -- 12/519
2018-06-21 12:24:07,033:INFO: Anemia Recall-at-100: 0.00%
2018-06-21 12:24:07,034:INFO: Experiment Progress: 2.0% -- 13/519
2018-06-21 12:24:07,459:INFO: Cholangiocarcinoma Recall-at-100: 8.33%
2018-06-21 12:24:07,459:INFO: Experiment Progress: 2.0% -- 14/519
2018-06-21 12:24:07,761:INFO: Neuroendocrine Tumors Recall-at-100: 0.00%
2018-06-21 12:24:07,761:INFO: Experiment Progress: 2.0% -- 15/519
2018-06-21 12:24:08,131:INFO: Malaria Recall-at-100: 5.00%
2018-06-21 12:24:08,132:INFO: Experiment Progress: 3.0% -- 16/519
2018-06-21 12:24:08,430:INFO: Hyperhomocysteinemia Recall-at-100: 10.00%
2018-06-21 12:24:08,430:INFO: Experiment Progress: 3.0% -- 17/519
2018-06-21 12:24:09,760:INFO: HIV Infections Recall-at-100: 9.00%
2018-06-21 12:24:09,760:INFO: Experiment Progress: 3.0% -- 18/519
2018-06-21 12:24:10,214:INFO: Ankylosing spondylitis Recall-at-100: 5.00%
2018-06-21 12:24:10,214:INFO: Experiment Progress: 3.0% -- 19/519
2018-06-21 12:24:11,224:INFO: Adenoid Cystic Carcinoma Recall-at-100: 7.56%
2018-06-21 12:24:11,224:INFO: Experiment Progress: 3.0% -- 20/519
2018-06-21 12:24:12,725:INFO: Juvenile arthritis Recall-at-100: 2.44%
2018-06-21 12:24:12,726:INFO: Experiment Progress: 4.0% -- 21/519
2018-06-21 12:24:13,181:INFO: Neoplasms, Experimental Recall-at-100: 9.17%
2018-06-21 12:24:13,181:INFO: Experiment Progress: 4.0% -- 22/519
2018-06-21 12:24:13,603:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 5.00%
2018-06-21 12:24:13,604:INFO: Experiment Progress: 4.0% -- 23/519
2018-06-21 12:24:13,958:INFO: Alopecia Areata Recall-at-100: 33.33%
2018-06-21 12:24:13,958:INFO: Experiment Progress: 4.0% -- 24/519
2018-06-21 12:24:14,277:INFO: Alopecia Recall-at-100: 0.00%
2018-06-21 12:24:14,277:INFO: Experiment Progress: 4.0% -- 25/519
2018-06-21 12:24:14,648:INFO: Bradycardia Recall-at-100: 10.00%
2018-06-21 12:24:14,649:INFO: Experiment Progress: 5.0% -- 26/519
2018-06-21 12:24:14,950:INFO: Common Variable Immunodeficiency Recall-at-100: 25.00%
2018-06-21 12:24:14,950:INFO: Experiment Progress: 5.0% -- 27/519
2018-06-21 12:24:15,376:INFO: Glomerulonephritis Recall-at-100: 6.67%
2018-06-21 12:24:15,376:INFO: Experiment Progress: 5.0% -- 28/519
2018-06-21 12:24:15,889:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 0.00%
2018-06-21 12:24:15,889:INFO: Experiment Progress: 5.0% -- 29/519
2018-06-21 12:24:16,264:INFO: Lung Injury Recall-at-100: 0.00%
2018-06-21 12:24:16,264:INFO: Experiment Progress: 5.0% -- 30/519
2018-06-21 12:24:16,571:INFO: Hypercalcemia Recall-at-100: 10.00%
2018-06-21 12:24:16,572:INFO: Experiment Progress: 5.0% -- 31/519
2018-06-21 12:24:17,067:INFO: Cerebrovascular accident Recall-at-100: 7.50%
2018-06-21 12:24:17,067:INFO: Experiment Progress: 6.0% -- 32/519
2018-06-21 12:24:17,555:INFO: Diaphragmatic Hernia Recall-at-100: 0.00%
2018-06-21 12:24:17,555:INFO: Experiment Progress: 6.0% -- 33/519
2018-06-21 12:24:17,841:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 15.00%
2018-06-21 12:24:17,841:INFO: Experiment Progress: 6.0% -- 34/519
2018-06-21 12:24:18,215:INFO: Migraine Disorders Recall-at-100: 0.00%
2018-06-21 12:24:18,215:INFO: Experiment Progress: 6.0% -- 35/519
2018-06-21 12:24:18,379:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-06-21 12:24:18,379:INFO: Experiment Progress: 6.0% -- 36/519
2018-06-21 12:24:18,680:INFO: Brugada Syndrome (disorder) Recall-at-100: 0.00%
2018-06-21 12:24:18,680:INFO: Experiment Progress: 7.0% -- 37/519
2018-06-21 12:24:18,943:INFO: Pathological accumulation of air in tissues Recall-at-100: 0.00%
2018-06-21 12:24:18,943:INFO: Experiment Progress: 7.0% -- 38/519
2018-06-21 12:24:19,210:INFO: Craniosynostosis Recall-at-100: 0.00%
2018-06-21 12:24:19,211:INFO: Experiment Progress: 7.0% -- 39/519
2018-06-21 12:24:19,568:INFO: Head and Neck Neoplasms Recall-at-100: 5.00%
2018-06-21 12:24:19,569:INFO: Experiment Progress: 7.0% -- 40/519
2018-06-21 12:24:19,983:INFO: Brain Neoplasms Recall-at-100: 23.33%
2018-06-21 12:24:19,983:INFO: Experiment Progress: 7.0% -- 41/519
2018-06-21 12:24:20,372:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-06-21 12:24:20,372:INFO: Experiment Progress: 8.0% -- 42/519
2018-06-21 12:24:20,699:INFO: Chromosome Aberrations Recall-at-100: 5.00%
2018-06-21 12:24:20,699:INFO: Experiment Progress: 8.0% -- 43/519
2018-06-21 12:24:21,316:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 2.00%
2018-06-21 12:24:21,316:INFO: Experiment Progress: 8.0% -- 44/519
2018-06-21 12:24:21,662:INFO: Refractive Errors Recall-at-100: 0.00%
2018-06-21 12:24:21,662:INFO: Experiment Progress: 8.0% -- 45/519
2018-06-21 12:24:21,956:INFO: Hepatitis C Recall-at-100: 0.00%
2018-06-21 12:24:21,959:INFO: Experiment Progress: 8.0% -- 46/519
2018-06-21 12:24:22,513:INFO: Mesothelioma Recall-at-100: 5.00%
2018-06-21 12:24:22,513:INFO: Experiment Progress: 9.0% -- 47/519
2018-06-21 12:24:22,779:INFO: Noise-induced hearing loss Recall-at-100: 0.00%
2018-06-21 12:24:22,779:INFO: Experiment Progress: 9.0% -- 48/519
2018-06-21 12:24:23,210:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-06-21 12:24:23,210:INFO: Experiment Progress: 9.0% -- 49/519
2018-06-21 12:24:23,563:INFO: Kallmann Syndrome Recall-at-100: 15.00%
2018-06-21 12:24:23,563:INFO: Experiment Progress: 9.0% -- 50/519
2018-06-21 12:24:23,900:INFO: Lipoidosis Recall-at-100: 15.00%
2018-06-21 12:24:23,900:INFO: Experiment Progress: 9.0% -- 51/519
2018-06-21 12:24:24,328:INFO: Diabetes Mellitus Recall-at-100: 0.00%
2018-06-21 12:24:24,329:INFO: Experiment Progress: 10.0% -- 52/519
2018-06-21 12:24:24,807:INFO: Fibrosis Recall-at-100: 7.50%
2018-06-21 12:24:24,807:INFO: Experiment Progress: 10.0% -- 53/519
2018-06-21 12:24:25,193:INFO: Hypercholesterolemia Recall-at-100: 0.00%
2018-06-21 12:24:25,193:INFO: Experiment Progress: 10.0% -- 54/519
2018-06-21 12:24:25,547:INFO: Microcephaly Recall-at-100: 0.00%
2018-06-21 12:24:25,547:INFO: Experiment Progress: 10.0% -- 55/519
2018-06-21 12:24:25,821:INFO: Tongue Neoplasms Recall-at-100: 10.00%
2018-06-21 12:24:25,822:INFO: Experiment Progress: 10.0% -- 56/519
2018-06-21 12:24:26,127:INFO: Common Migraine Recall-at-100: 0.00%
2018-06-21 12:24:26,127:INFO: Experiment Progress: 10.0% -- 57/519
2018-06-21 12:24:26,404:INFO: Carotid Artery Diseases Recall-at-100: 10.00%
2018-06-21 12:24:26,405:INFO: Experiment Progress: 11.0% -- 58/519
2018-06-21 12:24:26,844:INFO: Growth Disorders Recall-at-100: 3.33%
2018-06-21 12:24:26,844:INFO: Experiment Progress: 11.0% -- 59/519
2018-06-21 12:24:27,118:INFO: Absence Epilepsy Recall-at-100: 0.00%
2018-06-21 12:24:27,118:INFO: Experiment Progress: 11.0% -- 60/519
2018-06-21 12:24:27,466:INFO: Epilepsy, Temporal Lobe Recall-at-100: 5.00%
2018-06-21 12:24:27,467:INFO: Experiment Progress: 11.0% -- 61/519
2018-06-21 12:24:27,920:INFO: Memory Disorders Recall-at-100: 5.83%
2018-06-21 12:24:27,920:INFO: Experiment Progress: 11.0% -- 62/519
2018-06-21 12:24:28,222:INFO: Catalepsy Recall-at-100: 5.00%
2018-06-21 12:24:28,223:INFO: Experiment Progress: 12.0% -- 63/519
2018-06-21 12:24:28,530:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 40.00%
2018-06-21 12:24:28,530:INFO: Experiment Progress: 12.0% -- 64/519
2018-06-21 12:24:28,956:INFO: Acute Promyelocytic Leukemia Recall-at-100: 13.33%
2018-06-21 12:24:28,956:INFO: Experiment Progress: 12.0% -- 65/519
2018-06-21 12:24:29,226:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 10.00%
2018-06-21 12:24:29,226:INFO: Experiment Progress: 12.0% -- 66/519
2018-06-21 12:24:29,462:INFO: Gout Recall-at-100: 0.00%
2018-06-21 12:24:29,462:INFO: Experiment Progress: 12.0% -- 67/519
2018-06-21 12:24:30,082:INFO: Coronary Artery Disease Recall-at-100: 3.67%
2018-06-21 12:24:30,082:INFO: Experiment Progress: 13.0% -- 68/519
2018-06-21 12:24:30,497:INFO: Venous Thromboembolism Recall-at-100: 10.00%
2018-06-21 12:24:30,497:INFO: Experiment Progress: 13.0% -- 69/519
2018-06-21 12:24:31,232:INFO: Precancerous Conditions Recall-at-100: 2.86%
2018-06-21 12:24:31,232:INFO: Experiment Progress: 13.0% -- 70/519
2018-06-21 12:24:32,066:INFO: Crohn Disease Recall-at-100: 0.00%
2018-06-21 12:24:32,066:INFO: Experiment Progress: 13.0% -- 71/519
2018-06-21 12:24:32,441:INFO: Uterine Cervical Neoplasm Recall-at-100: 18.33%
2018-06-21 12:24:32,442:INFO: Experiment Progress: 13.0% -- 72/519
2018-06-21 12:24:32,744:INFO: Dyskinesia, Drug-Induced Recall-at-100: 0.00%
2018-06-21 12:24:32,745:INFO: Experiment Progress: 14.0% -- 73/519
2018-06-21 12:24:33,062:INFO: Ataxia, Spinocerebellar Recall-at-100: 5.00%
2018-06-21 12:24:33,062:INFO: Experiment Progress: 14.0% -- 74/519
2018-06-21 12:24:33,152:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 0.00%
2018-06-21 12:24:33,152:INFO: Experiment Progress: 14.0% -- 75/519
2018-06-21 12:24:33,467:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 10.00%
2018-06-21 12:24:33,467:INFO: Experiment Progress: 14.0% -- 76/519
2018-06-21 12:24:33,796:INFO: Acute Lung Injury Recall-at-100: 0.00%
2018-06-21 12:24:33,797:INFO: Experiment Progress: 14.0% -- 77/519
2018-06-21 12:24:34,737:INFO: Liver Cirrhosis, Experimental Recall-at-100: 1.91%
2018-06-21 12:24:34,737:INFO: Experiment Progress: 15.0% -- 78/519
2018-06-21 12:24:35,159:INFO: Chloracne Recall-at-100: 10.00%
2018-06-21 12:24:35,159:INFO: Experiment Progress: 15.0% -- 79/519
2018-06-21 12:24:35,812:INFO: Liver diseases Recall-at-100: 3.33%
2018-06-21 12:24:35,812:INFO: Experiment Progress: 15.0% -- 80/519
2018-06-21 12:24:36,293:INFO: Kidney Failure, Chronic Recall-at-100: 2.50%
2018-06-21 12:24:36,293:INFO: Experiment Progress: 15.0% -- 81/519
2018-06-21 12:24:36,643:INFO: Weight decreased Recall-at-100: 0.00%
2018-06-21 12:24:36,643:INFO: Experiment Progress: 15.0% -- 82/519
2018-06-21 12:24:36,991:INFO: Leigh Disease Recall-at-100: 50.00%
2018-06-21 12:24:36,991:INFO: Experiment Progress: 15.0% -- 83/519
2018-06-21 12:24:37,477:INFO: Celiac Disease Recall-at-100: 2.50%
2018-06-21 12:24:37,477:INFO: Experiment Progress: 16.0% -- 84/519
2018-06-21 12:24:37,849:INFO: Glaucoma Recall-at-100: 0.00%
2018-06-21 12:24:37,849:INFO: Experiment Progress: 16.0% -- 85/519
2018-06-21 12:24:38,146:INFO: Tachycardia Recall-at-100: 0.00%
2018-06-21 12:24:38,146:INFO: Experiment Progress: 16.0% -- 86/519
2018-06-21 12:24:38,460:INFO: Breast Cancer, Familial Recall-at-100: 70.00%
2018-06-21 12:24:38,460:INFO: Experiment Progress: 16.0% -- 87/519
2018-06-21 12:24:38,852:INFO: Ischemia Recall-at-100: 8.33%
2018-06-21 12:24:38,852:INFO: Experiment Progress: 16.0% -- 88/519
2018-06-21 12:24:39,062:INFO: Adenomatous Polyposis Coli Recall-at-100: 0.00%
2018-06-21 12:24:39,062:INFO: Experiment Progress: 17.0% -- 89/519
2018-06-21 12:24:39,351:INFO: Thyroid Diseases Recall-at-100: 0.00%
2018-06-21 12:24:39,352:INFO: Experiment Progress: 17.0% -- 90/519
2018-06-21 12:24:39,595:INFO: Panic Disorder Recall-at-100: 0.00%
2018-06-21 12:24:39,595:INFO: Experiment Progress: 17.0% -- 91/519
2018-06-21 12:24:41,317:INFO: Colorectal Neoplasms Recall-at-100: 4.24%
2018-06-21 12:24:41,317:INFO: Experiment Progress: 17.0% -- 92/519
2018-06-21 12:24:41,626:INFO: Adrenal Gland Neoplasms Recall-at-100: 10.00%
2018-06-21 12:24:41,627:INFO: Experiment Progress: 17.0% -- 93/519
2018-06-21 12:24:41,859:INFO: Sudden infant death syndrome Recall-at-100: 33.33%
2018-06-21 12:24:41,859:INFO: Experiment Progress: 18.0% -- 94/519
2018-06-21 12:24:42,418:INFO: Neuroblastoma Recall-at-100: 6.50%
2018-06-21 12:24:42,418:INFO: Experiment Progress: 18.0% -- 95/519
2018-06-21 12:24:42,700:INFO: Prostate cancer, familial Recall-at-100: 15.00%
2018-06-21 12:24:42,700:INFO: Experiment Progress: 18.0% -- 96/519
2018-06-21 12:24:43,830:INFO: Animal Mammary Neoplasms Recall-at-100: 8.19%
2018-06-21 12:24:43,830:INFO: Experiment Progress: 18.0% -- 97/519
2018-06-21 12:24:44,130:INFO: Osteochondrodysplasias Recall-at-100: 25.00%
2018-06-21 12:24:44,130:INFO: Experiment Progress: 18.0% -- 98/519
2018-06-21 12:24:44,513:INFO: Hepatolenticular Degeneration Recall-at-100: 0.00%
2018-06-21 12:24:44,513:INFO: Experiment Progress: 19.0% -- 99/519
2018-06-21 12:24:44,876:INFO: Fanconi Anemia Recall-at-100: 85.00%
2018-06-21 12:24:44,877:INFO: Experiment Progress: 19.0% -- 100/519
2018-06-21 12:24:45,170:INFO: Eye Abnormalities Recall-at-100: 30.00%
2018-06-21 12:24:45,170:INFO: Experiment Progress: 19.0% -- 101/519
2018-06-21 12:24:45,480:INFO: Limb Deformities, Congenital Recall-at-100: 0.00%
2018-06-21 12:24:45,480:INFO: Experiment Progress: 19.0% -- 102/519
2018-06-21 12:24:45,663:INFO: Electrocardiogram: P-R interval Recall-at-100: 0.00%
2018-06-21 12:24:45,663:INFO: Experiment Progress: 19.0% -- 103/519
2018-06-21 12:24:46,883:INFO: Mammary Neoplasms, Experimental Recall-at-100: 8.10%
2018-06-21 12:24:46,883:INFO: Experiment Progress: 20.0% -- 104/519
2018-06-21 12:24:47,281:INFO: Heart valve disease Recall-at-100: 0.00%
2018-06-21 12:24:47,281:INFO: Experiment Progress: 20.0% -- 105/519
2018-06-21 12:24:47,738:INFO: Diffuse Large B-Cell Lymphoma Recall-at-100: 2.50%
2018-06-21 12:24:47,738:INFO: Experiment Progress: 20.0% -- 106/519
2018-06-21 12:24:48,064:INFO: Hepatitis Recall-at-100: 0.00%
2018-06-21 12:24:48,064:INFO: Experiment Progress: 20.0% -- 107/519
2018-06-21 12:24:48,373:INFO: Impaired glucose tolerance Recall-at-100: 25.00%
2018-06-21 12:24:48,373:INFO: Experiment Progress: 20.0% -- 108/519
2018-06-21 12:24:48,639:INFO: Mitochondrial Encephalomyopathies Recall-at-100: 10.00%
2018-06-21 12:24:48,639:INFO: Experiment Progress: 21.0% -- 109/519
2018-06-21 12:24:49,023:INFO: Colon Carcinoma Recall-at-100: 20.00%
2018-06-21 12:24:49,023:INFO: Experiment Progress: 21.0% -- 110/519
2018-06-21 12:24:49,342:INFO: Hepatic Encephalopathy Recall-at-100: 0.00%
2018-06-21 12:24:49,342:INFO: Experiment Progress: 21.0% -- 111/519
2018-06-21 12:24:50,143:INFO: Multiple Sclerosis Recall-at-100: 2.50%
2018-06-21 12:24:50,144:INFO: Experiment Progress: 21.0% -- 112/519
2018-06-21 12:24:50,448:INFO: Neurogenic Inflammation Recall-at-100: 10.00%
2018-06-21 12:24:50,448:INFO: Experiment Progress: 21.0% -- 113/519
2018-06-21 12:24:51,163:INFO: Lupus Erythematosus, Systemic Recall-at-100: 0.00%
2018-06-21 12:24:51,164:INFO: Experiment Progress: 21.0% -- 114/519
2018-06-21 12:24:51,440:INFO: Ceroid lipofuscinosis, neuronal 1, infantile Recall-at-100: 10.00%
2018-06-21 12:24:51,440:INFO: Experiment Progress: 22.0% -- 115/519
2018-06-21 12:24:51,950:INFO: Adenocarcinoma of lung (disorder) Recall-at-100: 4.50%
2018-06-21 12:24:51,950:INFO: Experiment Progress: 22.0% -- 116/519
2018-06-21 12:24:52,374:INFO: Charcot-Marie-Tooth Disease Recall-at-100: 5.00%
2018-06-21 12:24:52,374:INFO: Experiment Progress: 22.0% -- 117/519
2018-06-21 12:24:52,668:INFO: Osteogenesis imperfecta type III (disorder) Recall-at-100: 20.00%
2018-06-21 12:24:52,668:INFO: Experiment Progress: 22.0% -- 118/519
2018-06-21 12:24:52,926:INFO: Osteogenesis imperfecta type IV (disorder) Recall-at-100: 20.00%
2018-06-21 12:24:52,926:INFO: Experiment Progress: 22.0% -- 119/519
2018-06-21 12:24:53,248:INFO: Hepatitis, Autoimmune Recall-at-100: 10.00%
2018-06-21 12:24:53,248:INFO: Experiment Progress: 23.0% -- 120/519
2018-06-21 12:24:56,810:INFO: Prostatic Neoplasms Recall-at-100: 5.36%
2018-06-21 12:24:56,810:INFO: Experiment Progress: 23.0% -- 121/519
2018-06-21 12:24:57,178:INFO: NADH:Q(1) Oxidoreductase deficiency Recall-at-100: 80.00%
2018-06-21 12:24:57,178:INFO: Experiment Progress: 23.0% -- 122/519
2018-06-21 12:24:57,488:INFO: Hypospadias Recall-at-100: 0.00%
2018-06-21 12:24:57,488:INFO: Experiment Progress: 23.0% -- 123/519
2018-06-21 12:24:57,926:INFO: Multiple Myeloma Recall-at-100: 9.17%
2018-06-21 12:24:57,927:INFO: Experiment Progress: 23.0% -- 124/519
2018-06-21 12:24:58,525:INFO: Fatty Liver Recall-at-100: 5.67%
2018-06-21 12:24:58,525:INFO: Experiment Progress: 24.0% -- 125/519
2018-06-21 12:24:58,800:INFO: Leishmaniasis, Visceral Recall-at-100: 0.00%
2018-06-21 12:24:58,800:INFO: Experiment Progress: 24.0% -- 126/519
2018-06-21 12:24:59,131:INFO: Early infantile epileptic encephalopathy with suppression bursts Recall-at-100: 0.00%
2018-06-21 12:24:59,131:INFO: Experiment Progress: 24.0% -- 127/519
2018-06-21 12:24:59,501:INFO: Kartagener Syndrome Recall-at-100: 5.00%
2018-06-21 12:24:59,502:INFO: Experiment Progress: 24.0% -- 128/519
2018-06-21 12:24:59,803:INFO: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Recall-at-100: 25.00%
2018-06-21 12:24:59,804:INFO: Experiment Progress: 24.0% -- 129/519
2018-06-21 12:25:00,556:INFO: Bipolar Disorder Recall-at-100: 0.00%
2018-06-21 12:25:00,557:INFO: Experiment Progress: 25.0% -- 130/519
2018-06-21 12:25:00,964:INFO: Erectile dysfunction Recall-at-100: 20.00%
2018-06-21 12:25:00,964:INFO: Experiment Progress: 25.0% -- 131/519
2018-06-21 12:25:01,609:INFO: Meckel-Gruber syndrome Recall-at-100: 45.00%
2018-06-21 12:25:01,610:INFO: Experiment Progress: 25.0% -- 132/519
2018-06-21 12:25:03,787:INFO: Colonic Neoplasms Recall-at-100: 5.71%
2018-06-21 12:25:03,787:INFO: Experiment Progress: 25.0% -- 133/519
2018-06-21 12:25:05,543:INFO: Autistic Disorder Recall-at-100: 0.43%
2018-06-21 12:25:05,543:INFO: Experiment Progress: 25.0% -- 134/519
2018-06-21 12:25:06,320:INFO: Liver Neoplasms, Experimental Recall-at-100: 1.67%
2018-06-21 12:25:06,321:INFO: Experiment Progress: 26.0% -- 135/519
2018-06-21 12:25:06,879:INFO: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 15.00%
2018-06-21 12:25:06,879:INFO: Experiment Progress: 26.0% -- 136/519
2018-06-21 12:25:07,320:INFO: Narcolepsy Recall-at-100: 20.00%
2018-06-21 12:25:07,320:INFO: Experiment Progress: 26.0% -- 137/519
2018-06-21 12:25:07,937:INFO: Fever Recall-at-100: 10.00%
2018-06-21 12:25:07,938:INFO: Experiment Progress: 26.0% -- 138/519
2018-06-21 12:25:09,420:INFO: Adenocarcinoma Recall-at-100: 8.64%
2018-06-21 12:25:09,420:INFO: Experiment Progress: 26.0% -- 139/519
2018-06-21 12:25:09,877:INFO: Aortic Valve Insufficiency Recall-at-100: 0.00%
2018-06-21 12:25:09,878:INFO: Experiment Progress: 26.0% -- 140/519
2018-06-21 12:25:10,313:INFO: Carcinoma, Pancreatic Ductal Recall-at-100: 30.00%
2018-06-21 12:25:10,313:INFO: Experiment Progress: 27.0% -- 141/519
2018-06-21 12:25:10,753:INFO: Infarction, Middle Cerebral Artery Recall-at-100: 15.00%
2018-06-21 12:25:10,753:INFO: Experiment Progress: 27.0% -- 142/519
2018-06-21 12:25:12,882:INFO: Hypertensive disease Recall-at-100: 3.86%
2018-06-21 12:25:12,883:INFO: Experiment Progress: 27.0% -- 143/519
2018-06-21 12:25:13,404:INFO: Juvenile Myelomonocytic Leukemia Recall-at-100: 5.00%
2018-06-21 12:25:13,404:INFO: Experiment Progress: 27.0% -- 144/519
2018-06-21 12:25:13,847:INFO: Leprosy Recall-at-100: 0.00%
2018-06-21 12:25:13,847:INFO: Experiment Progress: 27.0% -- 145/519
2018-06-21 12:25:14,756:INFO: Myocardial Infarction Recall-at-100: 3.61%
2018-06-21 12:25:14,756:INFO: Experiment Progress: 28.0% -- 146/519
2018-06-21 12:25:15,161:INFO: Urticaria Recall-at-100: 0.00%
2018-06-21 12:25:15,162:INFO: Experiment Progress: 28.0% -- 147/519
2018-06-21 12:25:15,479:INFO: Cardiac Arrhythmia Recall-at-100: 0.00%
2018-06-21 12:25:15,480:INFO: Experiment Progress: 28.0% -- 148/519
2018-06-21 12:25:15,793:INFO: Hemochromatosis Recall-at-100: 0.00%
2018-06-21 12:25:15,793:INFO: Experiment Progress: 28.0% -- 149/519
2018-06-21 12:25:16,636:INFO: Pancreatic Neoplasm Recall-at-100: 11.25%
2018-06-21 12:25:16,636:INFO: Experiment Progress: 28.0% -- 150/519
2018-06-21 12:25:17,236:INFO: Cardiomyopathy, Dilated Recall-at-100: 6.50%
2018-06-21 12:25:17,236:INFO: Experiment Progress: 29.0% -- 151/519
2018-06-21 12:25:17,635:INFO: Papilloma Recall-at-100: 10.00%
2018-06-21 12:25:17,635:INFO: Experiment Progress: 29.0% -- 152/519
2018-06-21 12:25:18,439:INFO: Pain Recall-at-100: 0.00%
2018-06-21 12:25:18,441:INFO: Experiment Progress: 29.0% -- 153/519
2018-06-21 12:25:18,743:INFO: Congenital Abnormality Recall-at-100: 22.22%
2018-06-21 12:25:18,743:INFO: Experiment Progress: 29.0% -- 154/519
2018-06-21 12:25:19,084:INFO: MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) Recall-at-100: 35.00%
2018-06-21 12:25:19,084:INFO: Experiment Progress: 29.0% -- 155/519
2018-06-21 12:25:19,919:INFO: Kidney Diseases Recall-at-100: 3.75%
2018-06-21 12:25:19,920:INFO: Experiment Progress: 30.0% -- 156/519
2018-06-21 12:25:20,229:INFO: Lung Diseases, Interstitial Recall-at-100: 0.00%
2018-06-21 12:25:20,229:INFO: Experiment Progress: 30.0% -- 157/519
2018-06-21 12:25:20,568:INFO: Basal cell carcinoma Recall-at-100: 10.00%
2018-06-21 12:25:20,568:INFO: Experiment Progress: 30.0% -- 158/519
2018-06-21 12:25:22,421:INFO: Liver carcinoma Recall-at-100: 7.90%
2018-06-21 12:25:22,421:INFO: Experiment Progress: 30.0% -- 159/519
2018-06-21 12:25:22,848:INFO: gliosarcoma Recall-at-100: 0.00%
2018-06-21 12:25:22,849:INFO: Experiment Progress: 30.0% -- 160/519
2018-06-21 12:25:23,521:INFO: Acute Coronary Syndrome Recall-at-100: 5.83%
2018-06-21 12:25:23,521:INFO: Experiment Progress: 31.0% -- 161/519
2018-06-21 12:25:24,303:INFO: Ovarian Cysts Recall-at-100: 0.00%
2018-06-21 12:25:24,303:INFO: Experiment Progress: 31.0% -- 162/519
2018-06-21 12:25:24,658:INFO: Schizophrenia, Childhood Recall-at-100: 0.00%
2018-06-21 12:25:24,658:INFO: Experiment Progress: 31.0% -- 163/519
2018-06-21 12:25:25,114:INFO: Adrenocortical carcinoma Recall-at-100: 35.00%
2018-06-21 12:25:25,114:INFO: Experiment Progress: 31.0% -- 164/519
2018-06-21 12:25:27,897:INFO: Schizophrenia Recall-at-100: 2.57%
2018-06-21 12:25:27,897:INFO: Experiment Progress: 31.0% -- 165/519
2018-06-21 12:25:28,320:INFO: Atrophic Recall-at-100: 0.00%
2018-06-21 12:25:28,321:INFO: Experiment Progress: 31.0% -- 166/519
2018-06-21 12:25:28,635:INFO: Idiopathic Pulmonary Fibrosis Recall-at-100: 0.00%
2018-06-21 12:25:28,636:INFO: Experiment Progress: 32.0% -- 167/519
2018-06-21 12:25:29,022:INFO: Lobar Holoprosencephaly Recall-at-100: 25.00%
2018-06-21 12:25:29,023:INFO: Experiment Progress: 32.0% -- 168/519
2018-06-21 12:25:29,456:INFO: Alobar Holoprosencephaly Recall-at-100: 25.00%
2018-06-21 12:25:29,457:INFO: Experiment Progress: 32.0% -- 169/519
2018-06-21 12:25:29,877:INFO: Immunologic Deficiency Syndromes Recall-at-100: 20.00%
2018-06-21 12:25:29,877:INFO: Experiment Progress: 32.0% -- 170/519
2018-06-21 12:25:30,250:INFO: Ataxia Recall-at-100: 10.00%
2018-06-21 12:25:30,251:INFO: Experiment Progress: 32.0% -- 171/519
2018-06-21 12:25:30,637:INFO: Adenocarcinoma Of Esophagus Recall-at-100: 10.00%
2018-06-21 12:25:30,637:INFO: Experiment Progress: 33.0% -- 172/519
2018-06-21 12:25:31,704:INFO: Retinitis Pigmentosa Recall-at-100: 9.05%
2018-06-21 12:25:31,704:INFO: Experiment Progress: 33.0% -- 173/519
2018-06-21 12:25:32,610:INFO: Squamous cell carcinoma of esophagus Recall-at-100: 6.11%
2018-06-21 12:25:32,611:INFO: Experiment Progress: 33.0% -- 174/519
2018-06-21 12:25:33,342:INFO: Autoimmune Diseases Recall-at-100: 0.00%
2018-06-21 12:25:33,342:INFO: Experiment Progress: 33.0% -- 175/519
2018-06-21 12:25:33,614:INFO: Diarrhea Recall-at-100: 22.22%
2018-06-21 12:25:33,614:INFO: Experiment Progress: 33.0% -- 176/519
2018-06-21 12:25:35,153:INFO: Myocardial Ischemia Recall-at-100: 1.76%
2018-06-21 12:25:35,153:INFO: Experiment Progress: 34.0% -- 177/519
2018-06-21 12:25:35,545:INFO: Essential Hypertension Recall-at-100: 0.00%
2018-06-21 12:25:35,545:INFO: Experiment Progress: 34.0% -- 178/519
2018-06-21 12:25:35,872:INFO: Hepatomegaly Recall-at-100: 0.00%
2018-06-21 12:25:35,873:INFO: Experiment Progress: 34.0% -- 179/519
2018-06-21 12:25:36,388:INFO: Myopathy Recall-at-100: 5.00%
2018-06-21 12:25:36,389:INFO: Experiment Progress: 34.0% -- 180/519
2018-06-21 12:25:37,044:INFO: Adverse reaction to drug Recall-at-100: 4.00%
2018-06-21 12:25:37,045:INFO: Experiment Progress: 34.0% -- 181/519
2018-06-21 12:25:37,338:INFO: Myoclonic Epilepsies, Progressive Recall-at-100: 0.00%
2018-06-21 12:25:37,338:INFO: Experiment Progress: 35.0% -- 182/519
2018-06-21 12:25:37,658:INFO: Muscular Atrophy Recall-at-100: 25.00%
2018-06-21 12:25:37,659:INFO: Experiment Progress: 35.0% -- 183/519
2018-06-21 12:25:38,015:INFO: Basal Ganglia Diseases Recall-at-100: 0.00%
2018-06-21 12:25:38,015:INFO: Experiment Progress: 35.0% -- 184/519
2018-06-21 12:25:38,374:INFO: Hepatitis B Recall-at-100: 25.00%
2018-06-21 12:25:38,375:INFO: Experiment Progress: 35.0% -- 185/519
2018-06-21 12:25:38,871:INFO: Lung diseases Recall-at-100: 0.00%
2018-06-21 12:25:38,871:INFO: Experiment Progress: 35.0% -- 186/519
2018-06-21 12:25:39,568:INFO: Chronic Obstructive Airway Disease Recall-at-100: 2.50%
2018-06-21 12:25:39,568:INFO: Experiment Progress: 36.0% -- 187/519
2018-06-21 12:25:42,089:INFO: Peripheral Neuropathy Recall-at-100: 2.62%
2018-06-21 12:25:42,090:INFO: Experiment Progress: 36.0% -- 188/519
2018-06-21 12:25:43,453:INFO: Weight Gain Recall-at-100: 4.72%
2018-06-21 12:25:43,453:INFO: Experiment Progress: 36.0% -- 189/519
2018-06-21 12:25:43,762:INFO: Deafness Recall-at-100: 5.00%
2018-06-21 12:25:43,763:INFO: Experiment Progress: 36.0% -- 190/519
2018-06-21 12:25:44,066:INFO: Renal dysplasia and retinal aplasia (disorder) Recall-at-100: 50.00%
2018-06-21 12:25:44,066:INFO: Experiment Progress: 36.0% -- 191/519
2018-06-21 12:25:44,530:INFO: Attention deficit hyperactivity disorder Recall-at-100: 0.00%
2018-06-21 12:25:44,530:INFO: Experiment Progress: 36.0% -- 192/519
2018-06-21 12:25:44,835:INFO: Tetralogy of Fallot Recall-at-100: 25.00%
2018-06-21 12:25:44,836:INFO: Experiment Progress: 37.0% -- 193/519
2018-06-21 12:25:45,287:INFO: Neurodegenerative Disorders Recall-at-100: 16.67%
2018-06-21 12:25:45,287:INFO: Experiment Progress: 37.0% -- 194/519
2018-06-21 12:25:45,605:INFO: Barrett Esophagus Recall-at-100: 0.00%
2018-06-21 12:25:45,605:INFO: Experiment Progress: 37.0% -- 195/519
2018-06-21 12:25:46,810:INFO: Craniofacial Abnormalities Recall-at-100: 3.48%
2018-06-21 12:25:46,810:INFO: Experiment Progress: 37.0% -- 196/519
2018-06-21 12:25:47,148:INFO: Necrotizing Enterocolitis Recall-at-100: 10.00%
2018-06-21 12:25:47,148:INFO: Experiment Progress: 37.0% -- 197/519
2018-06-21 12:25:47,489:INFO: Hyperlipidemia Recall-at-100: 5.00%
2018-06-21 12:25:47,489:INFO: Experiment Progress: 38.0% -- 198/519
2018-06-21 12:25:47,839:INFO: MYELODYSPLASTIC SYNDROME Recall-at-100: 5.00%
2018-06-21 12:25:47,839:INFO: Experiment Progress: 38.0% -- 199/519
2018-06-21 12:25:48,333:INFO: Anoxia Recall-at-100: 0.00%
2018-06-21 12:25:48,333:INFO: Experiment Progress: 38.0% -- 200/519
2018-06-21 12:25:49,058:INFO: Small cell carcinoma of lung Recall-at-100: 15.00%
2018-06-21 12:25:49,058:INFO: Experiment Progress: 38.0% -- 201/519
2018-06-21 12:25:49,703:INFO: Epilepsy Recall-at-100: 1.67%
2018-06-21 12:25:49,703:INFO: Experiment Progress: 38.0% -- 202/519
2018-06-21 12:25:50,029:INFO: Liver Failure, Acute Recall-at-100: 18.33%
2018-06-21 12:25:50,029:INFO: Experiment Progress: 39.0% -- 203/519
2018-06-21 12:25:50,354:INFO: Micronuclei, Chromosome-Defective Recall-at-100: 20.00%
2018-06-21 12:25:50,355:INFO: Experiment Progress: 39.0% -- 204/519
2018-06-21 12:25:50,711:INFO: Cognition Disorders Recall-at-100: 0.00%
2018-06-21 12:25:50,711:INFO: Experiment Progress: 39.0% -- 205/519
2018-06-21 12:25:50,976:INFO: Tonic-Clonic Epilepsy Recall-at-100: 0.00%
2018-06-21 12:25:50,977:INFO: Experiment Progress: 39.0% -- 206/519
2018-06-21 12:25:51,457:INFO: Heart Diseases Recall-at-100: 2.50%
2018-06-21 12:25:51,457:INFO: Experiment Progress: 39.0% -- 207/519
2018-06-21 12:25:51,859:INFO: Adult T-Cell Lymphoma/Leukemia Recall-at-100: 13.33%
2018-06-21 12:25:51,859:INFO: Experiment Progress: 40.0% -- 208/519
2018-06-21 12:25:52,187:INFO: Primary biliary cirrhosis Recall-at-100: 10.00%
2018-06-21 12:25:52,187:INFO: Experiment Progress: 40.0% -- 209/519
2018-06-21 12:25:52,449:INFO: beta Thalassemia Recall-at-100: 0.00%
2018-06-21 12:25:52,449:INFO: Experiment Progress: 40.0% -- 210/519
2018-06-21 12:25:52,709:INFO: Marijuana Abuse Recall-at-100: 0.00%
2018-06-21 12:25:52,710:INFO: Experiment Progress: 40.0% -- 211/519
2018-06-21 12:25:53,028:INFO: Long QT Syndrome Recall-at-100: 55.00%
2018-06-21 12:25:53,028:INFO: Experiment Progress: 40.0% -- 212/519
2018-06-21 12:25:53,367:INFO: Burkitt Lymphoma Recall-at-100: 10.00%
2018-06-21 12:25:53,367:INFO: Experiment Progress: 41.0% -- 213/519
2018-06-21 12:25:53,635:INFO: TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) Recall-at-100: 0.00%
2018-06-21 12:25:53,636:INFO: Experiment Progress: 41.0% -- 214/519
2018-06-21 12:25:54,123:INFO: Insulin Resistance Recall-at-100: 15.00%
2018-06-21 12:25:54,124:INFO: Experiment Progress: 41.0% -- 215/519
2018-06-21 12:25:54,484:INFO: Left Ventricular Hypertrophy Recall-at-100: 5.00%
2018-06-21 12:25:54,484:INFO: Experiment Progress: 41.0% -- 216/519
2018-06-21 12:25:54,753:INFO: Bronchial Hyperreactivity Recall-at-100: 0.00%
2018-06-21 12:25:54,753:INFO: Experiment Progress: 41.0% -- 217/519
2018-06-21 12:25:55,264:INFO: AMYOTROPHIC LATERAL SCLEROSIS 1 Recall-at-100: 11.00%
2018-06-21 12:25:55,265:INFO: Experiment Progress: 42.0% -- 218/519
2018-06-21 12:25:55,523:INFO: Fetal Growth Retardation Recall-at-100: 0.00%
2018-06-21 12:25:55,523:INFO: Experiment Progress: 42.0% -- 219/519
2018-06-21 12:25:55,727:INFO: Holoprosencephaly Recall-at-100: 0.00%
2018-06-21 12:25:55,727:INFO: Experiment Progress: 42.0% -- 220/519
2018-06-21 12:25:56,190:INFO: Arthritis, Experimental Recall-at-100: 2.50%
2018-06-21 12:25:56,190:INFO: Experiment Progress: 42.0% -- 221/519
2018-06-21 12:25:56,605:INFO: Congenital Heart Defects Recall-at-100: 6.67%
2018-06-21 12:25:56,605:INFO: Experiment Progress: 42.0% -- 222/519
2018-06-21 12:25:56,844:INFO: Pseudohypoaldosteronism Recall-at-100: 44.44%
2018-06-21 12:25:56,845:INFO: Experiment Progress: 42.0% -- 223/519
2018-06-21 12:25:57,176:INFO: Cataract Recall-at-100: 21.67%
2018-06-21 12:25:57,176:INFO: Experiment Progress: 43.0% -- 224/519
2018-06-21 12:25:57,465:INFO: Giant Cell Glioblastoma Recall-at-100: 10.00%
2018-06-21 12:25:57,465:INFO: Experiment Progress: 43.0% -- 225/519
2018-06-21 12:25:57,787:INFO: Seizure Adverse Event Recall-at-100: 0.00%
2018-06-21 12:25:57,787:INFO: Experiment Progress: 43.0% -- 226/519
2018-06-21 12:25:58,070:INFO: Body Weight Recall-at-100: 10.00%
2018-06-21 12:25:58,070:INFO: Experiment Progress: 43.0% -- 227/519
2018-06-21 12:25:58,351:INFO: Huntington Disease Recall-at-100: 0.00%
2018-06-21 12:25:58,351:INFO: Experiment Progress: 43.0% -- 228/519
2018-06-21 12:25:58,959:INFO: Glioblastoma Recall-at-100: 10.00%
2018-06-21 12:25:58,959:INFO: Experiment Progress: 44.0% -- 229/519
2018-06-21 12:25:59,226:INFO: Congenital diaphragmatic hernia Recall-at-100: 0.00%
2018-06-21 12:25:59,226:INFO: Experiment Progress: 44.0% -- 230/519
2018-06-21 12:25:59,571:INFO: Systemic Scleroderma Recall-at-100: 0.00%
2018-06-21 12:25:59,571:INFO: Experiment Progress: 44.0% -- 231/519
2018-06-21 12:26:00,176:INFO: Acute kidney injury Recall-at-100: 4.52%
2018-06-21 12:26:00,176:INFO: Experiment Progress: 44.0% -- 232/519
2018-06-21 12:26:00,448:INFO: Copper-Overload Cirrhosis Recall-at-100: 10.00%
2018-06-21 12:26:00,449:INFO: Experiment Progress: 44.0% -- 233/519
2018-06-21 12:26:01,273:INFO: Spontaneous abortion Recall-at-100: 5.11%
2018-06-21 12:26:01,273:INFO: Experiment Progress: 45.0% -- 234/519
2018-06-21 12:26:01,934:INFO: Glioma Recall-at-100: 9.05%
2018-06-21 12:26:01,934:INFO: Experiment Progress: 45.0% -- 235/519
2018-06-21 12:26:02,244:INFO: Gliosis Recall-at-100: 25.00%
2018-06-21 12:26:02,244:INFO: Experiment Progress: 45.0% -- 236/519
2018-06-21 12:26:02,498:INFO: LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 70.00%
2018-06-21 12:26:02,499:INFO: Experiment Progress: 45.0% -- 237/519
2018-06-21 12:26:02,730:INFO: Dementia Recall-at-100: 11.11%
2018-06-21 12:26:02,730:INFO: Experiment Progress: 45.0% -- 238/519
2018-06-21 12:26:03,068:INFO: Pancreatitis Recall-at-100: 0.00%
2018-06-21 12:26:03,069:INFO: Experiment Progress: 46.0% -- 239/519
2018-06-21 12:26:03,370:INFO: Amino Acid Metabolism, Inborn Errors Recall-at-100: 0.00%
2018-06-21 12:26:03,370:INFO: Experiment Progress: 46.0% -- 240/519
2018-06-21 12:26:03,796:INFO: Thyroid Neoplasm Recall-at-100: 3.33%
2018-06-21 12:26:03,796:INFO: Experiment Progress: 46.0% -- 241/519
2018-06-21 12:26:04,831:INFO: Neoplasm Invasiveness Recall-at-100: 11.67%
2018-06-21 12:26:04,831:INFO: Experiment Progress: 46.0% -- 242/519
2018-06-21 12:26:06,008:INFO: Neoplasm Metastasis Recall-at-100: 6.14%
2018-06-21 12:26:06,009:INFO: Experiment Progress: 46.0% -- 243/519
2018-06-21 12:26:06,348:INFO: Albuminuria Recall-at-100: 5.00%
2018-06-21 12:26:06,348:INFO: Experiment Progress: 47.0% -- 244/519
2018-06-21 12:26:06,655:INFO: Pre-Eclampsia Recall-at-100: 0.00%
2018-06-21 12:26:06,655:INFO: Experiment Progress: 47.0% -- 245/519
2018-06-21 12:26:07,334:INFO: Nerve Degeneration Recall-at-100: 11.43%
2018-06-21 12:26:07,335:INFO: Experiment Progress: 47.0% -- 246/519
2018-06-21 12:26:07,612:INFO: Thromboembolism Recall-at-100: 40.00%
2018-06-21 12:26:07,612:INFO: Experiment Progress: 47.0% -- 247/519
2018-06-21 12:26:08,772:INFO: Polycystic Ovary Syndrome Recall-at-100: 0.71%
2018-06-21 12:26:08,773:INFO: Experiment Progress: 47.0% -- 248/519
2018-06-21 12:26:09,042:INFO: Transient Ischemic Attack Recall-at-100: 0.00%
2018-06-21 12:26:09,042:INFO: Experiment Progress: 47.0% -- 249/519
2018-06-21 12:26:09,727:INFO: Brain Ischemia Recall-at-100: 20.00%
2018-06-21 12:26:09,727:INFO: Experiment Progress: 48.0% -- 250/519
2018-06-21 12:26:10,116:INFO: Cerebral Infarction Recall-at-100: 40.00%
2018-06-21 12:26:10,117:INFO: Experiment Progress: 48.0% -- 251/519
2018-06-21 12:26:10,771:INFO: Malignant neoplasm of esophagus Recall-at-100: 0.00%
2018-06-21 12:26:10,771:INFO: Experiment Progress: 48.0% -- 252/519
2018-06-21 12:26:11,875:INFO: Degenerative polyarthritis Recall-at-100: 8.78%
2018-06-21 12:26:11,876:INFO: Experiment Progress: 48.0% -- 253/519
2018-06-21 12:26:12,155:INFO: Osteitis Deformans Recall-at-100: 12.50%
2018-06-21 12:26:12,155:INFO: Experiment Progress: 48.0% -- 254/519
2018-06-21 12:26:12,506:INFO: Diabetic Cardiomyopathies Recall-at-100: 10.00%
2018-06-21 12:26:12,507:INFO: Experiment Progress: 49.0% -- 255/519
2018-06-21 12:26:12,851:INFO: Nuclear cataract Recall-at-100: 30.00%
2018-06-21 12:26:12,852:INFO: Experiment Progress: 49.0% -- 256/519
2018-06-21 12:26:13,191:INFO: Anorexia Recall-at-100: 20.00%
2018-06-21 12:26:13,192:INFO: Experiment Progress: 49.0% -- 257/519
2018-06-21 12:26:14,520:INFO: Cocaine-Related Disorders Recall-at-100: 6.81%
2018-06-21 12:26:14,521:INFO: Experiment Progress: 49.0% -- 258/519
2018-06-21 12:26:14,664:INFO: MELAS Syndrome Recall-at-100: 0.00%
2018-06-21 12:26:14,665:INFO: Experiment Progress: 49.0% -- 259/519
2018-06-21 12:26:14,850:INFO: Mitochondrial Myopathies Recall-at-100: 0.00%
2018-06-21 12:26:14,850:INFO: Experiment Progress: 50.0% -- 260/519
2018-06-21 12:26:15,674:INFO: Amphetamine-Related Disorders Recall-at-100: 1.43%
2018-06-21 12:26:15,674:INFO: Experiment Progress: 50.0% -- 261/519
2018-06-21 12:26:16,000:INFO: Birth Weight Recall-at-100: 0.00%
2018-06-21 12:26:16,000:INFO: Experiment Progress: 50.0% -- 262/519
2018-06-21 12:26:16,449:INFO: Brain Diseases Recall-at-100: 5.00%
2018-06-21 12:26:16,449:INFO: Experiment Progress: 50.0% -- 263/519
2018-06-21 12:26:16,793:INFO: Dyslipidemias Recall-at-100: 0.00%
2018-06-21 12:26:16,793:INFO: Experiment Progress: 50.0% -- 264/519
2018-06-21 12:26:17,059:INFO: Berylliosis Recall-at-100: 0.00%
2018-06-21 12:26:17,059:INFO: Experiment Progress: 51.0% -- 265/519
2018-06-21 12:26:17,456:INFO: Mental Retardation, X-Linked Recall-at-100: 0.00%
2018-06-21 12:26:17,456:INFO: Experiment Progress: 51.0% -- 266/519
2018-06-21 12:26:17,686:INFO: Sarcoidosis Recall-at-100: 0.00%
2018-06-21 12:26:17,686:INFO: Experiment Progress: 51.0% -- 267/519
2018-06-21 12:26:18,776:INFO: Liver neoplasms Recall-at-100: 4.91%
2018-06-21 12:26:18,776:INFO: Experiment Progress: 51.0% -- 268/519
2018-06-21 12:26:19,598:INFO: Myocardial Reperfusion Injury Recall-at-100: 8.00%
2018-06-21 12:26:19,598:INFO: Experiment Progress: 51.0% -- 269/519
2018-06-21 12:26:19,992:INFO: Microsatellite Instability Recall-at-100: 0.00%
2018-06-21 12:26:19,992:INFO: Experiment Progress: 52.0% -- 270/519
2018-06-21 12:26:20,275:INFO: Night blindness, congenital stationary Recall-at-100: 45.00%
2018-06-21 12:26:20,275:INFO: Experiment Progress: 52.0% -- 271/519
2018-06-21 12:26:21,343:INFO: Stevens-Johnson Syndrome Recall-at-100: 26.67%
2018-06-21 12:26:21,344:INFO: Experiment Progress: 52.0% -- 272/519
2018-06-21 12:26:21,834:INFO: Leukemia, Lymphocytic, Acute, L1 Recall-at-100: 0.00%
2018-06-21 12:26:21,835:INFO: Experiment Progress: 52.0% -- 273/519
2018-06-21 12:26:22,650:INFO: Systemic arterial pressure Recall-at-100: 0.00%
2018-06-21 12:26:22,652:INFO: Experiment Progress: 52.0% -- 274/519
2018-06-21 12:26:23,303:INFO: Learning Disorders Recall-at-100: 11.67%
2018-06-21 12:26:23,304:INFO: Experiment Progress: 52.0% -- 275/519
2018-06-21 12:26:23,803:INFO: Walker-Warburg congenital muscular dystrophy Recall-at-100: 25.00%
2018-06-21 12:26:23,804:INFO: Experiment Progress: 53.0% -- 276/519
2018-06-21 12:26:24,134:INFO: Marfan Syndrome Recall-at-100: 33.33%
2018-06-21 12:26:24,135:INFO: Experiment Progress: 53.0% -- 277/519
2018-06-21 12:26:24,597:INFO: Congenital ocular coloboma (disorder) Recall-at-100: 0.00%
2018-06-21 12:26:24,597:INFO: Experiment Progress: 53.0% -- 278/519
2018-06-21 12:26:27,024:INFO: Lung Neoplasms Recall-at-100: 10.88%
2018-06-21 12:26:27,024:INFO: Experiment Progress: 53.0% -- 279/519
2018-06-21 12:26:27,405:INFO: Myoclonic Epilepsy, Juvenile Recall-at-100: 0.00%
2018-06-21 12:26:27,405:INFO: Experiment Progress: 53.0% -- 280/519
2018-06-21 12:26:28,362:INFO: Inflammatory Bowel Diseases Recall-at-100: 0.00%
2018-06-21 12:26:28,362:INFO: Experiment Progress: 54.0% -- 281/519
2018-06-21 12:26:31,827:INFO: Mammary Neoplasms Recall-at-100: 7.60%
2018-06-21 12:26:31,827:INFO: Experiment Progress: 54.0% -- 282/519
2018-06-21 12:26:32,040:INFO: Idiopathic generalized epilepsy Recall-at-100: 0.00%
2018-06-21 12:26:32,040:INFO: Experiment Progress: 54.0% -- 283/519
2018-06-21 12:26:32,504:INFO: Neuralgia Recall-at-100: 0.00%
2018-06-21 12:26:32,505:INFO: Experiment Progress: 54.0% -- 284/519
2018-06-21 12:26:33,125:INFO: Neural Tube Defects Recall-at-100: 8.33%
2018-06-21 12:26:33,125:INFO: Experiment Progress: 54.0% -- 285/519
2018-06-21 12:26:34,093:INFO: Dermatitis, Allergic Contact Recall-at-100: 1.67%
2018-06-21 12:26:34,094:INFO: Experiment Progress: 55.0% -- 286/519
2018-06-21 12:26:34,413:INFO: Inborn Errors of Metabolism Recall-at-100: 0.00%
2018-06-21 12:26:34,413:INFO: Experiment Progress: 55.0% -- 287/519
2018-06-21 12:26:34,829:INFO: Platelet mean volume finding Recall-at-100: 0.00%
2018-06-21 12:26:34,830:INFO: Experiment Progress: 55.0% -- 288/519
2018-06-21 12:26:35,101:INFO: Intestinal Neoplasms Recall-at-100: 10.00%
2018-06-21 12:26:35,101:INFO: Experiment Progress: 55.0% -- 289/519
2018-06-21 12:26:35,347:INFO: Allergic rhinitis (disorder) Recall-at-100: 0.00%
2018-06-21 12:26:35,348:INFO: Experiment Progress: 55.0% -- 290/519
2018-06-21 12:26:35,956:INFO: Blood pressure finding Recall-at-100: 0.00%
2018-06-21 12:26:35,957:INFO: Experiment Progress: 56.0% -- 291/519
2018-06-21 12:26:36,515:INFO: Age related macular degeneration Recall-at-100: 6.67%
2018-06-21 12:26:36,515:INFO: Experiment Progress: 56.0% -- 292/519
2018-06-21 12:26:36,923:INFO: Hyperplasia Recall-at-100: 5.00%
2018-06-21 12:26:36,923:INFO: Experiment Progress: 56.0% -- 293/519
2018-06-21 12:26:37,344:INFO: Pulmonary function (finding) Recall-at-100: 0.00%
2018-06-21 12:26:37,344:INFO: Experiment Progress: 56.0% -- 294/519
2018-06-21 12:26:37,707:INFO: Spina Bifida Recall-at-100: 0.00%
2018-06-21 12:26:37,708:INFO: Experiment Progress: 56.0% -- 295/519
2018-06-21 12:26:38,112:INFO: Hypertrophic Cardiomyopathy Recall-at-100: 18.33%
2018-06-21 12:26:38,112:INFO: Experiment Progress: 57.0% -- 296/519
2018-06-21 12:26:38,553:INFO: Bardet-Biedl Syndrome Recall-at-100: 51.67%
2018-06-21 12:26:38,553:INFO: Experiment Progress: 57.0% -- 297/519
2018-06-21 12:26:39,220:INFO: Keloid Recall-at-100: 0.00%
2018-06-21 12:26:39,220:INFO: Experiment Progress: 57.0% -- 298/519
2018-06-21 12:26:40,789:INFO: melanoma Recall-at-100: 5.41%
2018-06-21 12:26:40,789:INFO: Experiment Progress: 57.0% -- 299/519
2018-06-21 12:26:41,144:INFO: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 Recall-at-100: 10.00%
2018-06-21 12:26:41,144:INFO: Experiment Progress: 57.0% -- 300/519
2018-06-21 12:26:41,631:INFO: Pneumonia Recall-at-100: 8.50%
2018-06-21 12:26:41,631:INFO: Experiment Progress: 57.0% -- 301/519
2018-06-21 12:26:42,677:INFO: Disease Progression Recall-at-100: 7.24%
2018-06-21 12:26:42,678:INFO: Experiment Progress: 58.0% -- 302/519
2018-06-21 12:26:42,987:INFO: Nephroblastoma Recall-at-100: 0.00%
2018-06-21 12:26:42,987:INFO: Experiment Progress: 58.0% -- 303/519
2018-06-21 12:26:43,279:INFO: Severe Combined Immunodeficiency Recall-at-100: 20.00%
2018-06-21 12:26:43,279:INFO: Experiment Progress: 58.0% -- 304/519
2018-06-21 12:26:43,557:INFO: Malignant neoplasm of ovary Recall-at-100: 5.00%
2018-06-21 12:26:43,557:INFO: Experiment Progress: 58.0% -- 305/519
2018-06-21 12:26:43,856:INFO: Pheochromocytoma Recall-at-100: 0.00%
2018-06-21 12:26:43,857:INFO: Experiment Progress: 58.0% -- 306/519
2018-06-21 12:26:44,242:INFO: Testicular Germ Cell Tumor Recall-at-100: 0.00%
2018-06-21 12:26:44,242:INFO: Experiment Progress: 59.0% -- 307/519
2018-06-21 12:26:44,512:INFO: Hypogonadism Recall-at-100: 0.00%
2018-06-21 12:26:44,512:INFO: Experiment Progress: 59.0% -- 308/519
2018-06-21 12:26:44,848:INFO: Movement Disorders Recall-at-100: 18.33%
2018-06-21 12:26:44,848:INFO: Experiment Progress: 59.0% -- 309/519
2018-06-21 12:26:45,134:INFO: Sarcoma Recall-at-100: 15.00%
2018-06-21 12:26:45,134:INFO: Experiment Progress: 59.0% -- 310/519
2018-06-21 12:26:45,548:INFO: Lymphatic Metastasis Recall-at-100: 20.00%
2018-06-21 12:26:45,548:INFO: Experiment Progress: 59.0% -- 311/519
2018-06-21 12:26:45,896:INFO: Hypoglycemia Recall-at-100: 0.00%
2018-06-21 12:26:45,897:INFO: Experiment Progress: 60.0% -- 312/519
2018-06-21 12:26:46,184:INFO: Anemia, Sickle Cell Recall-at-100: 10.00%
2018-06-21 12:26:46,184:INFO: Experiment Progress: 60.0% -- 313/519
2018-06-21 12:26:46,538:INFO: Muscular Dystrophy, Facioscapulohumeral Recall-at-100: 0.00%
2018-06-21 12:26:46,538:INFO: Experiment Progress: 60.0% -- 314/519
2018-06-21 12:26:47,086:INFO: Colorectal Cancer Recall-at-100: 20.00%
2018-06-21 12:26:47,086:INFO: Experiment Progress: 60.0% -- 315/519
2018-06-21 12:26:49,048:INFO: Atherosclerosis Recall-at-100: 3.67%
2018-06-21 12:26:49,049:INFO: Experiment Progress: 60.0% -- 316/519
2018-06-21 12:26:50,450:INFO: Asthma Recall-at-100: 3.00%
2018-06-21 12:26:50,451:INFO: Experiment Progress: 61.0% -- 317/519
2018-06-21 12:26:50,884:INFO: Cardiomyopathy, Hypertrophic, Familial Recall-at-100: 36.67%
2018-06-21 12:26:50,884:INFO: Experiment Progress: 61.0% -- 318/519
2018-06-21 12:26:51,566:INFO: Skin Neoplasms Recall-at-100: 7.00%
2018-06-21 12:26:51,566:INFO: Experiment Progress: 61.0% -- 319/519
2018-06-21 12:26:53,166:INFO: Seizures Recall-at-100: 1.00%
2018-06-21 12:26:53,167:INFO: Experiment Progress: 61.0% -- 320/519
2018-06-21 12:26:54,838:INFO: Alzheimer's Disease Recall-at-100: 6.59%
2018-06-21 12:26:54,838:INFO: Experiment Progress: 61.0% -- 321/519
2018-06-21 12:26:55,217:INFO: Menopause present (finding) Recall-at-100: 0.00%
2018-06-21 12:26:55,218:INFO: Experiment Progress: 62.0% -- 322/519
2018-06-21 12:26:55,853:INFO: Neoplastic Syndromes, Hereditary Recall-at-100: 29.00%
2018-06-21 12:26:55,853:INFO: Experiment Progress: 62.0% -- 323/519
2018-06-21 12:26:56,176:INFO: Gastrointestinal Diseases Recall-at-100: 10.00%
2018-06-21 12:26:56,176:INFO: Experiment Progress: 62.0% -- 324/519
2018-06-21 12:26:56,613:INFO: Cytochrome-c Oxidase Deficiency Recall-at-100: 0.00%
2018-06-21 12:26:56,614:INFO: Experiment Progress: 62.0% -- 325/519
2018-06-21 12:26:57,278:INFO: Retinal Degeneration Recall-at-100: 5.00%
2018-06-21 12:26:57,278:INFO: Experiment Progress: 62.0% -- 326/519
2018-06-21 12:26:58,002:INFO: Retinal Diseases Recall-at-100: 0.00%
2018-06-21 12:26:58,002:INFO: Experiment Progress: 63.0% -- 327/519
2018-06-21 12:26:58,518:INFO: Methylmalonic acidemia Recall-at-100: 11.11%
2018-06-21 12:26:58,519:INFO: Experiment Progress: 63.0% -- 328/519
2018-06-21 12:26:59,970:INFO: Contact Dermatitis Recall-at-100: 5.71%
2018-06-21 12:26:59,971:INFO: Experiment Progress: 63.0% -- 329/519
2018-06-21 12:27:01,384:INFO: Dermatitis, Atopic Recall-at-100: 7.50%
2018-06-21 12:27:01,384:INFO: Experiment Progress: 63.0% -- 330/519
2018-06-21 12:27:03,094:INFO: Coronary heart disease Recall-at-100: 2.00%
2018-06-21 12:27:03,094:INFO: Experiment Progress: 63.0% -- 331/519
2018-06-21 12:27:04,326:INFO: Osteoporosis Recall-at-100: 3.33%
2018-06-21 12:27:04,326:INFO: Experiment Progress: 63.0% -- 332/519
2018-06-21 12:27:05,903:INFO: Cardiomegaly Recall-at-100: 11.43%
2018-06-21 12:27:05,903:INFO: Experiment Progress: 64.0% -- 333/519
2018-06-21 12:27:07,340:INFO: Heart failure Recall-at-100: 6.61%
2018-06-21 12:27:07,340:INFO: Experiment Progress: 64.0% -- 334/519
2018-06-21 12:27:07,783:INFO: Hereditary Breast and Ovarian Cancer Syndrome Recall-at-100: 85.00%
2018-06-21 12:27:07,783:INFO: Experiment Progress: 64.0% -- 335/519
2018-06-21 12:27:08,377:INFO: Major Depressive Disorder Recall-at-100: 3.33%
2018-06-21 12:27:08,378:INFO: Experiment Progress: 64.0% -- 336/519
2018-06-21 12:27:09,078:INFO: Dermatologic disorders Recall-at-100: 0.00%
2018-06-21 12:27:09,078:INFO: Experiment Progress: 64.0% -- 337/519
2018-06-21 12:27:10,138:INFO: Inflammation Recall-at-100: 0.91%
2018-06-21 12:27:10,138:INFO: Experiment Progress: 65.0% -- 338/519
2018-06-21 12:27:10,449:INFO: Diabetic Neuropathies Recall-at-100: 5.00%
2018-06-21 12:27:10,449:INFO: Experiment Progress: 65.0% -- 339/519
2018-06-21 12:27:10,925:INFO: Male infertility Recall-at-100: 10.00%
2018-06-21 12:27:10,925:INFO: Experiment Progress: 65.0% -- 340/519
2018-06-21 12:27:11,236:INFO: Vascular Diseases Recall-at-100: 0.00%
2018-06-21 12:27:11,236:INFO: Experiment Progress: 65.0% -- 341/519
2018-06-21 12:27:11,646:INFO: Female infertility Recall-at-100: 21.67%
2018-06-21 12:27:11,646:INFO: Experiment Progress: 65.0% -- 342/519
2018-06-21 12:27:12,084:INFO: leukemia Recall-at-100: 9.17%
2018-06-21 12:27:12,084:INFO: Experiment Progress: 66.0% -- 343/519
2018-06-21 12:27:12,877:INFO: Ulcerative Colitis Recall-at-100: 1.25%
2018-06-21 12:27:12,877:INFO: Experiment Progress: 66.0% -- 344/519
2018-06-21 12:27:13,417:INFO: Influenza Recall-at-100: 16.50%
2018-06-21 12:27:13,417:INFO: Experiment Progress: 66.0% -- 345/519
2018-06-21 12:27:13,668:INFO: Nephritis, Interstitial Recall-at-100: 0.00%
2018-06-21 12:27:13,668:INFO: Experiment Progress: 66.0% -- 346/519
2018-06-21 12:27:13,966:INFO: Sjogren's Syndrome Recall-at-100: 15.00%
2018-06-21 12:27:13,967:INFO: Experiment Progress: 66.0% -- 347/519
2018-06-21 12:27:14,263:INFO: Infant length Recall-at-100: 0.00%
2018-06-21 12:27:14,263:INFO: Experiment Progress: 67.0% -- 348/519
2018-06-21 12:27:14,959:INFO: Child Development Disorders, Pervasive Recall-at-100: 2.00%
2018-06-21 12:27:14,959:INFO: Experiment Progress: 67.0% -- 349/519
2018-06-21 12:27:15,477:INFO: Substance Withdrawal Syndrome Recall-at-100: 4.00%
2018-06-21 12:27:15,477:INFO: Experiment Progress: 67.0% -- 350/519
2018-06-21 12:27:15,748:INFO: Malformations of Cortical Development Recall-at-100: 0.00%
2018-06-21 12:27:15,748:INFO: Experiment Progress: 67.0% -- 351/519
2018-06-21 12:27:16,467:INFO: Amyotrophic Lateral Sclerosis Recall-at-100: 10.95%
2018-06-21 12:27:16,467:INFO: Experiment Progress: 67.0% -- 352/519
2018-06-21 12:27:17,261:INFO: Developmental Disabilities Recall-at-100: 0.00%
2018-06-21 12:27:17,262:INFO: Experiment Progress: 68.0% -- 353/519
2018-06-21 12:27:17,561:INFO: Febrile Convulsions Recall-at-100: 0.00%
2018-06-21 12:27:17,562:INFO: Experiment Progress: 68.0% -- 354/519
2018-06-21 12:27:18,044:INFO: Cholestasis Recall-at-100: 2.50%
2018-06-21 12:27:18,044:INFO: Experiment Progress: 68.0% -- 355/519
2018-06-21 12:27:18,454:INFO: Pulmonary Hypertension Recall-at-100: 0.00%
2018-06-21 12:27:18,455:INFO: Experiment Progress: 68.0% -- 356/519
2018-06-21 12:27:18,860:INFO: Papillary thyroid carcinoma Recall-at-100: 13.33%
2018-06-21 12:27:18,860:INFO: Experiment Progress: 68.0% -- 357/519
2018-06-21 12:27:19,380:INFO: Salivary Gland Neoplasms Recall-at-100: 2.50%
2018-06-21 12:27:19,380:INFO: Experiment Progress: 68.0% -- 358/519
2018-06-21 12:27:19,841:INFO: Non-alcoholic Fatty Liver Disease Recall-at-100: 0.00%
2018-06-21 12:27:19,842:INFO: Experiment Progress: 69.0% -- 359/519
2018-06-21 12:27:20,123:INFO: Hay fever Recall-at-100: 0.00%
2018-06-21 12:27:20,123:INFO: Experiment Progress: 69.0% -- 360/519
2018-06-21 12:27:20,474:INFO: Hypercholesterolemia, Familial Recall-at-100: 0.00%
2018-06-21 12:27:20,474:INFO: Experiment Progress: 69.0% -- 361/519
2018-06-21 12:27:21,350:INFO: Down Syndrome Recall-at-100: 3.33%
2018-06-21 12:27:21,350:INFO: Experiment Progress: 69.0% -- 362/519
2018-06-21 12:27:21,628:INFO: Arrhythmogenic Right Ventricular Dysplasia Recall-at-100: 30.00%
2018-06-21 12:27:21,628:INFO: Experiment Progress: 69.0% -- 363/519
2018-06-21 12:27:21,948:INFO: Semilobar Holoprosencephaly Recall-at-100: 25.00%
2018-06-21 12:27:21,948:INFO: Experiment Progress: 70.0% -- 364/519
2018-06-21 12:27:22,273:INFO: Hypertriglyceridemia Recall-at-100: 10.00%
2018-06-21 12:27:22,273:INFO: Experiment Progress: 70.0% -- 365/519
2018-06-21 12:27:22,518:INFO: Sensorineural Hearing Loss (disorder) Recall-at-100: 11.11%
2018-06-21 12:27:22,519:INFO: Experiment Progress: 70.0% -- 366/519
2018-06-21 12:27:23,017:INFO: Metabolic Syndrome X Recall-at-100: 2.50%
2018-06-21 12:27:23,017:INFO: Experiment Progress: 70.0% -- 367/519
2018-06-21 12:27:23,347:INFO: Malignant neoplasm of lung Recall-at-100: 15.00%
2018-06-21 12:27:23,347:INFO: Experiment Progress: 70.0% -- 368/519
2018-06-21 12:27:24,320:INFO: Leukemia, Myelocytic, Acute Recall-at-100: 1.82%
2018-06-21 12:27:24,320:INFO: Experiment Progress: 71.0% -- 369/519
2018-06-21 12:27:24,986:INFO: Malignant neoplasm of prostate Recall-at-100: 6.43%
2018-06-21 12:27:24,987:INFO: Experiment Progress: 71.0% -- 370/519
2018-06-21 12:27:25,256:INFO: Renal Insufficiency Recall-at-100: 20.00%
2018-06-21 12:27:25,256:INFO: Experiment Progress: 71.0% -- 371/519
2018-06-21 12:27:25,493:INFO: Jeune thoracic dystrophy Recall-at-100: 55.56%
2018-06-21 12:27:25,494:INFO: Experiment Progress: 71.0% -- 372/519
2018-06-21 12:27:26,562:INFO: Renal Cell Carcinoma Recall-at-100: 5.08%
2018-06-21 12:27:26,562:INFO: Experiment Progress: 71.0% -- 373/519
2018-06-21 12:27:27,386:INFO: Squamous cell carcinoma Recall-at-100: 14.72%
2018-06-21 12:27:27,386:INFO: Experiment Progress: 72.0% -- 374/519
2018-06-21 12:27:28,413:INFO: Non-Small Cell Lung Carcinoma Recall-at-100: 6.45%
2018-06-21 12:27:28,413:INFO: Experiment Progress: 72.0% -- 375/519
2018-06-21 12:27:28,742:INFO: Manganese Poisoning Recall-at-100: 0.00%
2018-06-21 12:27:28,742:INFO: Experiment Progress: 72.0% -- 376/519
2018-06-21 12:27:29,226:INFO: Ventricular Dysfunction, Left Recall-at-100: 0.00%
2018-06-21 12:27:29,228:INFO: Experiment Progress: 72.0% -- 377/519
2018-06-21 12:27:29,966:INFO: Carcinoma, Transitional Cell Recall-at-100: 21.67%
2018-06-21 12:27:29,970:INFO: Experiment Progress: 72.0% -- 378/519
2018-06-21 12:27:30,437:INFO: Mucocutaneous Lymph Node Syndrome Recall-at-100: 0.00%
2018-06-21 12:27:30,438:INFO: Experiment Progress: 73.0% -- 379/519
2018-06-21 12:27:31,019:INFO: Tobacco Use Disorder Recall-at-100: 0.00%
2018-06-21 12:27:31,020:INFO: Experiment Progress: 73.0% -- 380/519
2018-06-21 12:27:31,545:INFO: Proteinuria Recall-at-100: 13.33%
2018-06-21 12:27:31,545:INFO: Experiment Progress: 73.0% -- 381/519
2018-06-21 12:27:32,081:INFO: Diabetic Nephropathy Recall-at-100: 2.50%
2018-06-21 12:27:32,081:INFO: Experiment Progress: 73.0% -- 382/519
2018-06-21 12:27:32,364:INFO: Williams Syndrome Recall-at-100: 0.00%
2018-06-21 12:27:32,364:INFO: Experiment Progress: 73.0% -- 383/519
2018-06-21 12:27:32,703:INFO: Oral Submucous Fibrosis Recall-at-100: 45.00%
2018-06-21 12:27:32,703:INFO: Experiment Progress: 73.0% -- 384/519
2018-06-21 12:27:33,163:INFO: Adenoma Recall-at-100: 3.33%
2018-06-21 12:27:33,164:INFO: Experiment Progress: 74.0% -- 385/519
2018-06-21 12:27:33,475:INFO: Neutropenia Recall-at-100: 0.00%
2018-06-21 12:27:33,475:INFO: Experiment Progress: 74.0% -- 386/519
2018-06-21 12:27:33,766:INFO: Poor school performance Recall-at-100: 0.00%
2018-06-21 12:27:33,766:INFO: Experiment Progress: 74.0% -- 387/519
2018-06-21 12:27:34,093:INFO: Pneumoconiosis Recall-at-100: 0.00%
2018-06-21 12:27:34,093:INFO: Experiment Progress: 74.0% -- 388/519
2018-06-21 12:27:34,873:INFO: Cardiovascular Diseases Recall-at-100: 2.00%
2018-06-21 12:27:34,873:INFO: Experiment Progress: 74.0% -- 389/519
2018-06-21 12:27:35,380:INFO: Fibrinogen Adverse Event Recall-at-100: 5.00%
2018-06-21 12:27:35,380:INFO: Experiment Progress: 75.0% -- 390/519
2018-06-21 12:27:36,987:INFO: Diabetes Mellitus, Non-Insulin-Dependent Recall-at-100: 5.21%
2018-06-21 12:27:36,988:INFO: Experiment Progress: 75.0% -- 391/519
2018-06-21 12:27:37,524:INFO: Thrombocytopenia Recall-at-100: 5.00%
2018-06-21 12:27:37,525:INFO: Experiment Progress: 75.0% -- 392/519
2018-06-21 12:27:38,120:INFO: Sezary Syndrome Recall-at-100: 21.67%
2018-06-21 12:27:38,121:INFO: Experiment Progress: 75.0% -- 393/519
2018-06-21 12:27:38,463:INFO: Nuclear non-senile cataract Recall-at-100: 30.00%
2018-06-21 12:27:38,463:INFO: Experiment Progress: 75.0% -- 394/519
2018-06-21 12:27:38,792:INFO: Diabetic Retinopathy Recall-at-100: 0.00%
2018-06-21 12:27:38,793:INFO: Experiment Progress: 76.0% -- 395/519
2018-06-21 12:27:39,347:INFO: hearing impairment Recall-at-100: 0.00%
2018-06-21 12:27:39,347:INFO: Experiment Progress: 76.0% -- 396/519
2018-06-21 12:27:39,693:INFO: Psychotic Disorders Recall-at-100: 15.00%
2018-06-21 12:27:39,693:INFO: Experiment Progress: 76.0% -- 397/519
2018-06-21 12:27:40,140:INFO: Anxiety Disorders Recall-at-100: 6.67%
2018-06-21 12:27:40,140:INFO: Experiment Progress: 76.0% -- 398/519
2018-06-21 12:27:40,446:INFO: Finding of Mean Corpuscular Hemoglobin Recall-at-100: 10.00%
2018-06-21 12:27:40,446:INFO: Experiment Progress: 76.0% -- 399/519
2018-06-21 12:27:40,750:INFO: Motion Sickness Recall-at-100: 0.00%
2018-06-21 12:27:40,751:INFO: Experiment Progress: 77.0% -- 400/519
2018-06-21 12:27:41,120:INFO: Lymphoma, Non-Hodgkin Recall-at-100: 5.00%
2018-06-21 12:27:41,120:INFO: Experiment Progress: 77.0% -- 401/519
2018-06-21 12:27:41,496:INFO: Lymphoma, Follicular Recall-at-100: 15.00%
2018-06-21 12:27:41,496:INFO: Experiment Progress: 77.0% -- 402/519
2018-06-21 12:27:41,789:INFO: Thrombocythemia, Essential Recall-at-100: 0.00%
2018-06-21 12:27:41,790:INFO: Experiment Progress: 77.0% -- 403/519
2018-06-21 12:27:42,046:INFO: Arthritis Recall-at-100: 0.00%
2018-06-21 12:27:42,046:INFO: Experiment Progress: 77.0% -- 404/519
2018-06-21 12:27:42,754:INFO: Hypotension Recall-at-100: 8.00%
2018-06-21 12:27:42,754:INFO: Experiment Progress: 78.0% -- 405/519
2018-06-21 12:27:43,837:INFO: Reperfusion Injury Recall-at-100: 13.19%
2018-06-21 12:27:43,837:INFO: Experiment Progress: 78.0% -- 406/519
2018-06-21 12:27:44,118:INFO: Heat Stroke Recall-at-100: 70.00%
2018-06-21 12:27:44,118:INFO: Experiment Progress: 78.0% -- 407/519
2018-06-21 12:27:44,569:INFO: Hemangiosarcoma Recall-at-100: 30.00%
2018-06-21 12:27:44,570:INFO: Experiment Progress: 78.0% -- 408/519
2018-06-21 12:27:45,066:INFO: Drug Allergy Recall-at-100: 0.00%
2018-06-21 12:27:45,066:INFO: Experiment Progress: 78.0% -- 409/519
2018-06-21 12:27:45,447:INFO: SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR Recall-at-100: 25.00%
2018-06-21 12:27:45,447:INFO: Experiment Progress: 78.0% -- 410/519
2018-06-21 12:27:46,090:INFO: Medulloblastoma Recall-at-100: 12.00%
2018-06-21 12:27:46,090:INFO: Experiment Progress: 79.0% -- 411/519
2018-06-21 12:27:46,641:INFO: Cleft Lip Recall-at-100: 28.33%
2018-06-21 12:27:46,641:INFO: Experiment Progress: 79.0% -- 412/519
2018-06-21 12:27:47,333:INFO: Cleft Palate Recall-at-100: 17.50%
2018-06-21 12:27:47,333:INFO: Experiment Progress: 79.0% -- 413/519
2018-06-21 12:27:48,556:INFO: Muscle Weakness Recall-at-100: 1.25%
2018-06-21 12:27:48,556:INFO: Experiment Progress: 79.0% -- 414/519
2018-06-21 12:27:48,847:INFO: Mental disorders Recall-at-100: 0.00%
2018-06-21 12:27:48,847:INFO: Experiment Progress: 79.0% -- 415/519
2018-06-21 12:27:49,201:INFO: Astrocytoma Recall-at-100: 21.67%
2018-06-21 12:27:49,201:INFO: Experiment Progress: 80.0% -- 416/519
2018-06-21 12:27:49,542:INFO: Anemia, Diamond-Blackfan Recall-at-100: 80.00%
2018-06-21 12:27:49,542:INFO: Experiment Progress: 80.0% -- 417/519
2018-06-21 12:27:49,849:INFO: Asthma, Aspirin-Induced Recall-at-100: 5.00%
2018-06-21 12:27:49,849:INFO: Experiment Progress: 80.0% -- 418/519
2018-06-21 12:27:50,215:INFO: Leber Congenital Amaurosis Recall-at-100: 0.00%
2018-06-21 12:27:50,216:INFO: Experiment Progress: 80.0% -- 419/519
2018-06-21 12:27:50,509:INFO: Cachexia Recall-at-100: 30.00%
2018-06-21 12:27:50,509:INFO: Experiment Progress: 80.0% -- 420/519
2018-06-21 12:27:50,772:INFO: Respiratory Insufficiency Recall-at-100: 0.00%
2018-06-21 12:27:50,772:INFO: Experiment Progress: 81.0% -- 421/519
2018-06-21 12:27:51,125:INFO: Respiratory Hypersensitivity Recall-at-100: 0.00%
2018-06-21 12:27:51,125:INFO: Experiment Progress: 81.0% -- 422/519
2018-06-21 12:27:51,492:INFO: Nasopharyngeal carcinoma Recall-at-100: 15.00%
2018-06-21 12:27:51,492:INFO: Experiment Progress: 81.0% -- 423/519
2018-06-21 12:27:52,223:INFO: Hyperalgesia Recall-at-100: 7.38%
2018-06-21 12:27:52,223:INFO: Experiment Progress: 81.0% -- 424/519
2018-06-21 12:27:52,659:INFO: Meningioma Recall-at-100: 10.00%
2018-06-21 12:27:52,659:INFO: Experiment Progress: 81.0% -- 425/519
2018-06-21 12:27:53,024:INFO: Sudden Cardiac Arrest Recall-at-100: 0.00%
2018-06-21 12:27:53,025:INFO: Experiment Progress: 82.0% -- 426/519
2018-06-21 12:27:54,199:INFO: Intellectual Disability Recall-at-100: 1.54%
2018-06-21 12:27:54,199:INFO: Experiment Progress: 82.0% -- 427/519
2018-06-21 12:27:54,505:INFO: Graves Disease Recall-at-100: 0.00%
2018-06-21 12:27:54,505:INFO: Experiment Progress: 82.0% -- 428/519
2018-06-21 12:27:54,882:INFO: Neurotoxicity Syndromes Recall-at-100: 11.67%
2018-06-21 12:27:54,883:INFO: Experiment Progress: 82.0% -- 429/519
2018-06-21 12:27:55,148:INFO: Cardiomyopathy, Familial Hypertrophic, 1 (disorder) Recall-at-100: 10.00%
2018-06-21 12:27:55,148:INFO: Experiment Progress: 82.0% -- 430/519
2018-06-21 12:27:55,513:INFO: Atrial Fibrillation Recall-at-100: 8.33%
2018-06-21 12:27:55,514:INFO: Experiment Progress: 83.0% -- 431/519
2018-06-21 12:27:55,912:INFO: Hepatitis, Chronic Recall-at-100: 15.00%
2018-06-21 12:27:55,913:INFO: Experiment Progress: 83.0% -- 432/519
2018-06-21 12:27:56,537:INFO: Behcet Syndrome Recall-at-100: 15.00%
2018-06-21 12:27:56,538:INFO: Experiment Progress: 83.0% -- 433/519
2018-06-21 12:27:57,646:INFO: Diabetes Mellitus, Insulin-Dependent Recall-at-100: 1.43%
2018-06-21 12:27:57,646:INFO: Experiment Progress: 83.0% -- 434/519
2018-06-21 12:27:58,665:INFO: Diabetes Mellitus, Experimental Recall-at-100: 7.91%
2018-06-21 12:27:58,665:INFO: Experiment Progress: 83.0% -- 435/519
2018-06-21 12:27:59,192:INFO: Parkinsonian Disorders Recall-at-100: 15.00%
2018-06-21 12:27:59,193:INFO: Experiment Progress: 84.0% -- 436/519
2018-06-21 12:27:59,778:INFO: Necrosis Recall-at-100: 6.00%
2018-06-21 12:27:59,779:INFO: Experiment Progress: 84.0% -- 437/519
2018-06-21 12:28:00,067:INFO: Gestational Diabetes Recall-at-100: 0.00%
2018-06-21 12:28:00,067:INFO: Experiment Progress: 84.0% -- 438/519
2018-06-21 12:28:00,446:INFO: Idiopathic Membranous Glomerulonephritis Recall-at-100: 0.00%
2018-06-21 12:28:00,446:INFO: Experiment Progress: 84.0% -- 439/519
2018-06-21 12:28:01,163:INFO: Hypersensitivity Recall-at-100: 8.67%
2018-06-21 12:28:01,164:INFO: Experiment Progress: 84.0% -- 440/519
2018-06-21 12:28:01,778:INFO: Myopia Recall-at-100: 6.67%
2018-06-21 12:28:01,778:INFO: Experiment Progress: 84.0% -- 441/519
2018-06-21 12:28:02,076:INFO: Hyperemia Recall-at-100: 0.00%
2018-06-21 12:28:02,076:INFO: Experiment Progress: 85.0% -- 442/519
2018-06-21 12:28:02,380:INFO: Tooth Abnormalities Recall-at-100: 0.00%
2018-06-21 12:28:02,380:INFO: Experiment Progress: 85.0% -- 443/519
2018-06-21 12:28:02,722:INFO: Hyperglycemia Recall-at-100: 5.00%
2018-06-21 12:28:02,723:INFO: Experiment Progress: 85.0% -- 444/519
2018-06-21 12:28:03,181:INFO: Noonan Syndrome Recall-at-100: 65.00%
2018-06-21 12:28:03,181:INFO: Experiment Progress: 85.0% -- 445/519
2018-06-21 12:28:03,535:INFO: Hyperinsulinism Recall-at-100: 0.00%
2018-06-21 12:28:03,535:INFO: Experiment Progress: 85.0% -- 446/519
2018-06-21 12:28:03,905:INFO: Edema Recall-at-100: 6.67%
2018-06-21 12:28:03,906:INFO: Experiment Progress: 86.0% -- 447/519
2018-06-21 12:28:04,357:INFO: Hodgkin Disease Recall-at-100: 0.00%
2018-06-21 12:28:04,358:INFO: Experiment Progress: 86.0% -- 448/519
2018-06-21 12:28:04,703:INFO: Metabolic Bone Disorder Recall-at-100: 0.00%
2018-06-21 12:28:04,704:INFO: Experiment Progress: 86.0% -- 449/519
2018-06-21 12:28:05,114:INFO: Bone Diseases, Developmental Recall-at-100: 0.00%
2018-06-21 12:28:05,114:INFO: Experiment Progress: 86.0% -- 450/519
2018-06-21 12:28:05,408:INFO: Tachycardia, Ventricular Recall-at-100: 0.00%
2018-06-21 12:28:05,408:INFO: Experiment Progress: 86.0% -- 451/519
2018-06-21 12:28:05,714:INFO: Dystonia Recall-at-100: 0.00%
2018-06-21 12:28:05,714:INFO: Experiment Progress: 87.0% -- 452/519
2018-06-21 12:28:06,103:INFO: Squamous cell carcinoma of the head and neck Recall-at-100: 16.67%
2018-06-21 12:28:06,103:INFO: Experiment Progress: 87.0% -- 453/519
2018-06-21 12:28:06,547:INFO: Pulmonary Embolism Recall-at-100: 20.00%
2018-06-21 12:28:06,547:INFO: Experiment Progress: 87.0% -- 454/519
2018-06-21 12:28:07,039:INFO: Pulmonary Fibrosis Recall-at-100: 7.00%
2018-06-21 12:28:07,039:INFO: Experiment Progress: 87.0% -- 455/519
2018-06-21 12:28:07,337:INFO: West Syndrome Recall-at-100: 0.00%
2018-06-21 12:28:07,337:INFO: Experiment Progress: 87.0% -- 456/519
2018-06-21 12:28:07,731:INFO: Cerebral Hemorrhage Recall-at-100: 35.00%
2018-06-21 12:28:07,731:INFO: Experiment Progress: 88.0% -- 457/519
2018-06-21 12:28:08,124:INFO: Romano-Ward Syndrome Recall-at-100: 35.00%
2018-06-21 12:28:08,125:INFO: Experiment Progress: 88.0% -- 458/519
2018-06-21 12:28:08,649:INFO: Mouth Neoplasms Recall-at-100: 10.00%
2018-06-21 12:28:08,650:INFO: Experiment Progress: 88.0% -- 459/519
2018-06-21 12:28:09,306:INFO: Liver Cirrhosis Recall-at-100: 10.00%
2018-06-21 12:28:09,307:INFO: Experiment Progress: 88.0% -- 460/519
2018-06-21 12:28:09,698:INFO: Neoplasm Recurrence, Local Recall-at-100: 11.67%
2018-06-21 12:28:09,698:INFO: Experiment Progress: 88.0% -- 461/519
2018-06-21 12:28:11,985:INFO: Obesity Recall-at-100: 1.92%
2018-06-21 12:28:11,985:INFO: Experiment Progress: 89.0% -- 462/519
2018-06-21 12:28:12,457:INFO: Biliary cirrhosis Recall-at-100: 0.00%
2018-06-21 12:28:12,458:INFO: Experiment Progress: 89.0% -- 463/519
2018-06-21 12:28:13,012:INFO: Precursor Cell Lymphoblastic Leukemia Lymphoma Recall-at-100: 10.83%
2018-06-21 12:28:13,012:INFO: Experiment Progress: 89.0% -- 464/519
2018-06-21 12:28:13,957:INFO: Cardiomyopathies Recall-at-100: 4.58%
2018-06-21 12:28:13,958:INFO: Experiment Progress: 89.0% -- 465/519
2018-06-21 12:28:14,264:INFO: Peroxisome biogenesis disorders Recall-at-100: 100.00%
2018-06-21 12:28:14,264:INFO: Experiment Progress: 89.0% -- 466/519
2018-06-21 12:28:14,574:INFO: Dyskeratosis Congenita Recall-at-100: 55.00%
2018-06-21 12:28:14,574:INFO: Experiment Progress: 89.0% -- 467/519
2018-06-21 12:28:14,913:INFO: Uremia Recall-at-100: 0.00%
2018-06-21 12:28:14,913:INFO: Experiment Progress: 90.0% -- 468/519
2018-06-21 12:28:15,399:INFO: Depressive disorder Recall-at-100: 3.33%
2018-06-21 12:28:15,399:INFO: Experiment Progress: 90.0% -- 469/519
2018-06-21 12:28:15,878:INFO: Thrombosis Recall-at-100: 34.17%
2018-06-21 12:28:15,878:INFO: Experiment Progress: 90.0% -- 470/519
2018-06-21 12:28:16,460:INFO: nervous system disorder Recall-at-100: 2.00%
2018-06-21 12:28:16,461:INFO: Experiment Progress: 90.0% -- 471/519
2018-06-21 12:28:16,795:INFO: Lymphoma Recall-at-100: 10.00%
2018-06-21 12:28:16,795:INFO: Experiment Progress: 90.0% -- 472/519
2018-06-21 12:28:20,325:INFO: IGA Glomerulonephritis Recall-at-100: 1.45%
2018-06-21 12:28:20,325:INFO: Experiment Progress: 91.0% -- 473/519
2018-06-21 12:28:20,702:INFO: Kidney Neoplasm Recall-at-100: 23.33%
2018-06-21 12:28:20,702:INFO: Experiment Progress: 91.0% -- 474/519
2018-06-21 12:28:20,936:INFO: Hypothermia, natural Recall-at-100: 0.00%
2018-06-21 12:28:20,936:INFO: Experiment Progress: 91.0% -- 475/519
2018-06-21 12:28:21,306:INFO: Focal glomerulosclerosis Recall-at-100: 20.00%
2018-06-21 12:28:21,306:INFO: Experiment Progress: 91.0% -- 476/519
2018-06-21 12:28:21,643:INFO: Hepatitis B, Chronic Recall-at-100: 0.00%
2018-06-21 12:28:21,643:INFO: Experiment Progress: 91.0% -- 477/519
2018-06-21 12:28:21,961:INFO: Drug Eruptions Recall-at-100: 20.00%
2018-06-21 12:28:21,961:INFO: Experiment Progress: 92.0% -- 478/519
2018-06-21 12:28:22,295:INFO: Malignant neoplasm of pancreas Recall-at-100: 0.00%
2018-06-21 12:28:22,295:INFO: Experiment Progress: 92.0% -- 479/519
2018-06-21 12:28:24,623:INFO: Stomach Neoplasms Recall-at-100: 4.72%
2018-06-21 12:28:24,623:INFO: Experiment Progress: 92.0% -- 480/519
2018-06-21 12:28:25,088:INFO: Osteosarcoma Recall-at-100: 16.67%
2018-06-21 12:28:25,088:INFO: Experiment Progress: 92.0% -- 481/519
2018-06-21 12:28:25,563:INFO: Vitiligo Recall-at-100: 0.00%
2018-06-21 12:28:25,563:INFO: Experiment Progress: 92.0% -- 482/519
2018-06-21 12:28:25,909:INFO: Gastric ulcer Recall-at-100: 0.00%
2018-06-21 12:28:25,909:INFO: Experiment Progress: 93.0% -- 483/519
2018-06-21 12:28:26,632:INFO: Malignant neoplasm of breast Recall-at-100: 6.67%
2018-06-21 12:28:26,632:INFO: Experiment Progress: 93.0% -- 484/519
2018-06-21 12:28:28,056:INFO: Drug-Induced Liver Injury Recall-at-100: 2.50%
2018-06-21 12:28:28,057:INFO: Experiment Progress: 93.0% -- 485/519
2018-06-21 12:28:28,516:INFO: Colitis Recall-at-100: 3.33%
2018-06-21 12:28:28,517:INFO: Experiment Progress: 93.0% -- 486/519
2018-06-21 12:28:28,860:INFO: Lymphoma, T-Cell, Cutaneous Recall-at-100: 5.00%
2018-06-21 12:28:28,860:INFO: Experiment Progress: 93.0% -- 487/519
2018-06-21 12:28:29,177:INFO: T-Cell Lymphoma Recall-at-100: 20.00%
2018-06-21 12:28:29,178:INFO: Experiment Progress: 94.0% -- 488/519
2018-06-21 12:28:29,593:INFO: Hyperactive behavior Recall-at-100: 0.00%
2018-06-21 12:28:29,594:INFO: Experiment Progress: 94.0% -- 489/519
2018-06-21 12:28:29,863:INFO: Skin Abnormalities Recall-at-100: 10.00%
2018-06-21 12:28:29,863:INFO: Experiment Progress: 94.0% -- 490/519
2018-06-21 12:28:30,218:INFO: Epithelial ovarian cancer Recall-at-100: 0.00%
2018-06-21 12:28:30,218:INFO: Experiment Progress: 94.0% -- 491/519
2018-06-21 12:28:30,637:INFO: Infantile Refsum Disease (disorder) Recall-at-100: 85.00%
2018-06-21 12:28:30,637:INFO: Experiment Progress: 94.0% -- 492/519
2018-06-21 12:28:30,957:INFO: Adrenoleukodystrophy, Neonatal Recall-at-100: 85.00%
2018-06-21 12:28:30,957:INFO: Experiment Progress: 94.0% -- 493/519
2018-06-21 12:28:31,221:INFO: Hirschsprung Disease Recall-at-100: 30.00%
2018-06-21 12:28:31,221:INFO: Experiment Progress: 95.0% -- 494/519
2018-06-21 12:28:31,542:INFO: Female Urogenital Diseases Recall-at-100: 5.00%
2018-06-21 12:28:31,542:INFO: Experiment Progress: 95.0% -- 495/519
2018-06-21 12:28:32,511:INFO: ovarian neoplasm Recall-at-100: 17.22%
2018-06-21 12:28:32,511:INFO: Experiment Progress: 95.0% -- 496/519
2018-06-21 12:28:32,795:INFO: Aortic Aneurysm, Abdominal Recall-at-100: 0.00%
2018-06-21 12:28:32,795:INFO: Experiment Progress: 95.0% -- 497/519
2018-06-21 12:28:33,131:INFO: Venous Thrombosis Recall-at-100: 25.00%
2018-06-21 12:28:33,132:INFO: Experiment Progress: 95.0% -- 498/519
2018-06-21 12:28:33,457:INFO: Amnesia Recall-at-100: 10.00%
2018-06-21 12:28:33,457:INFO: Experiment Progress: 96.0% -- 499/519
2018-06-21 12:28:34,430:INFO: Bladder Neoplasm Recall-at-100: 9.55%
2018-06-21 12:28:34,430:INFO: Experiment Progress: 96.0% -- 500/519
2018-06-21 12:28:34,737:INFO: Hemorrhage Recall-at-100: 5.00%
2018-06-21 12:28:34,737:INFO: Experiment Progress: 96.0% -- 501/519
2018-06-21 12:28:35,425:INFO: Status Epilepticus Recall-at-100: 5.95%
2018-06-21 12:28:35,425:INFO: Experiment Progress: 96.0% -- 502/519
2018-06-21 12:28:35,794:INFO: Chronic Kidney Diseases Recall-at-100: 0.00%
2018-06-21 12:28:35,794:INFO: Experiment Progress: 96.0% -- 503/519
2018-06-21 12:28:36,137:INFO: Myeloid Leukemia, Chronic Recall-at-100: 26.67%
2018-06-21 12:28:36,138:INFO: Experiment Progress: 97.0% -- 504/519
2018-06-21 12:28:36,474:INFO: Myeloid Leukemia Recall-at-100: 35.00%
2018-06-21 12:28:36,474:INFO: Experiment Progress: 97.0% -- 505/519
2018-06-21 12:28:36,964:INFO: Calcinosis Recall-at-100: 14.17%
2018-06-21 12:28:36,964:INFO: Experiment Progress: 97.0% -- 506/519
2018-06-21 12:28:37,250:INFO: Creutzfeldt-Jakob disease Recall-at-100: 0.00%
2018-06-21 12:28:37,251:INFO: Experiment Progress: 97.0% -- 507/519
2018-06-21 12:28:37,564:INFO: Left ventricular noncompaction Recall-at-100: 5.00%
2018-06-21 12:28:37,564:INFO: Experiment Progress: 97.0% -- 508/519
2018-06-21 12:28:38,436:INFO: Parkinson Disease Recall-at-100: 4.22%
2018-06-21 12:28:38,436:INFO: Experiment Progress: 98.0% -- 509/519
2018-06-21 12:28:39,054:INFO: Endometrial Neoplasms Recall-at-100: 8.00%
2018-06-21 12:28:39,054:INFO: Experiment Progress: 98.0% -- 510/519
2018-06-21 12:28:39,425:INFO: Sepsis Recall-at-100: 5.00%
2018-06-21 12:28:39,425:INFO: Experiment Progress: 98.0% -- 511/519
2018-06-21 12:28:40,925:INFO: Endometriosis Recall-at-100: 11.52%
2018-06-21 12:28:40,925:INFO: Experiment Progress: 98.0% -- 512/519
2018-06-21 12:28:41,659:INFO: Esophageal Neoplasms Recall-at-100: 10.24%
2018-06-21 12:28:41,659:INFO: Experiment Progress: 98.0% -- 513/519
2018-06-21 12:28:41,963:INFO: Eosinophilic esophagitis Recall-at-100: 0.00%
2018-06-21 12:28:41,963:INFO: Experiment Progress: 99.0% -- 514/519
2018-06-21 12:28:42,281:INFO: Malignant neoplasm of urinary bladder Recall-at-100: 0.00%
2018-06-21 12:28:42,281:INFO: Experiment Progress: 99.0% -- 515/519
2018-06-21 12:28:42,641:INFO: Lewy Body Disease Recall-at-100: 5.00%
2018-06-21 12:28:42,641:INFO: Experiment Progress: 99.0% -- 516/519
2018-06-21 12:28:42,964:INFO: PARKINSON DISEASE, LATE-ONSET Recall-at-100: 0.00%
2018-06-21 12:28:42,964:INFO: Experiment Progress: 99.0% -- 517/519
2018-06-21 12:28:43,885:INFO: Neoplastic Cell Transformation Recall-at-100: 7.92%
2018-06-21 12:28:43,885:INFO: Experiment Progress: 99.0% -- 518/519
2018-06-21 12:28:44,572:INFO: Arsenic Poisoning Recall-at-100: 4.00%
